<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0223523419303307</prism:url><dc:identifier>doi:10.1016/j.ejmech.2019.04.024</dc:identifier><eid>1-s2.0-S0223523419303307</eid><prism:doi>10.1016/j.ejmech.2019.04.024</prism:doi><pii>S0223-5234(19)30330-7</pii><dc:title>Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors </dc:title><prism:publicationName>European Journal of Medicinal Chemistry</prism:publicationname><prism:aggregationType>Journal</prism:aggregationtype><pubType>fla</pubtype><prism:issn>02235234</prism:issn><prism:volume>174</prism:volume><prism:startingPage>236</prism:startingpage><prism:endingPage>251</prism:endingpage><prism:pageRange>236-251</prism:pagerange><dc:format>text/xml</dc:format><prism:coverDate>2019-07-15</prism:coverdate><prism:coverDisplayDate>15 July 2019</prism:coverdisplaydate><prism:copyright>© 2019 Elsevier Masson SAS. All rights reserved.</prism:copyright><prism:publisher>Elsevier Masson SAS.</prism:publisher><dc:creator>Cai, Guiping</dc:creator><dc:creator>Yu, Wenying</dc:creator><dc:creator>Song, Dongmei</dc:creator><dc:creator>Zhang, Wenda</dc:creator><dc:creator>Guo, Jianpeng</dc:creator><dc:creator>Zhu, Jiawen</dc:creator><dc:creator>Ren, Yuhao</dc:creator><dc:creator>Kong, Lingyi</dc:creator><dc:description>
                  STAT3 has been extensively studied as a potential antitumor target. Though studies on regulating STAT3 mainly focus on the inhibition of STAT3 phosphorylation at Tyr705 residue, the phosphorylation at Ser727 residue of STAT3 protein is also closely associated with the mitochondrial import of STAT3 protein. N, N-diethyl-7-aminocoumarin is a fluorescent mitochondria-targeting probe. In this study, a series of STAT3 inhibitors were developed by connecting N, N-diethyl-7-aminocoumarin fluorophore with benzo [b]thiophene 1, 1-dioxide moiety. All designed compounds displayed potent anti-proliferative activity against cancer cells. The representative compound 7a was mainly accumulated in mitochondria visualized by its fluorescence. STAT3 phosphorylation was inhibited by compound 7a at both Tyr705 and Ser727 residues. Compound 7a inhibited STAT3 phosphorylation whereas had no influence on the phosphorylation levels of STAT1, JAK2, Src and Erk1/2, indicating good selectivity of compound 7a. Moreover, compound 7a down-regulated the expression of STAT3 target genes Bcl-2 and Cyclin D1, increased ROS production and remarkably reduced the mitochondrial membrane potential to induce mitochondrial apoptotic pathway. Furthermore, compound 7a 
                     in vivo suppressed breast cancer 4T1 implanted tumor growth. Taken together, these results highlighted that compound 7a might be a promising mitochondria-targeting STAT3 inhibitor for cancer therapy.
               </dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessarticle><openaccessType/></openaccesstype><openArchiveArticle>false</openarchivearticle><openaccessSponsorName/></openaccesssponsorname><openaccessSponsorType/></openaccesssponsortype><openaccessUserLicense/></openaccessuserlicense><dcterms:subject>STAT3</dcterms:subject><dcterms:subject>Benzo[b]thiophene 1, 1-Dioxide</dcterms:subject><dcterms:subject>
                     N, N-Diethyl-7-aminocoumarin fluorophore</dcterms:subject><dcterms:subject>Ser727 phosphorylation</dcterms:subject><dcterms:subject>Mitochondrial apoptosis pathway</dcterms:subject><dcterms:subject>Antitumor activity</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S0223523419303307" rel="self"/></link><link href="https://www.sciencedirect.com/science/article/pii/S0223523419303307" rel="scidir"/></link></coredata><objects><object ref="sc1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="624" height="412" size="48997">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-sc1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr6" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="580" height="275" size="40918">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref="gr9" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="669" height="661" size="97380">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr9.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="691" height="187" size="32573">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="535" height="357" size="50244">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="500" height="199" size="44050">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-fx1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr7" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="646" height="629" size="84156">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr7.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="735" height="688" size="131007">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="535" height="345" size="50244">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref="gr8" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="535" height="170" size="33437">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr8.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="669" height="371" size="58832">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref="sc1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="145" size="6174">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-sc1.sml?httpAccept=%2A%2F%2A</object><object ref="gr6" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="104" size="7157">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr6.sml?httpAccept=%2A%2F%2A</object><object ref="gr9" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="166" height="164" size="11272">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr9.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="59" size="8352">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="146" size="7302">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="fx1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="87" size="11552">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-fx1.sml?httpAccept=%2A%2F%2A</object><object ref="gr7" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="168" height="163" size="10353">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr7.sml?httpAccept=%2A%2F%2A</object><object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="175" height="164" size="10645">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr3.sml?httpAccept=%2A%2F%2A</object><object ref="gr4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="141" size="17179">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr4.sml?httpAccept=%2A%2F%2A</object><object ref="gr8" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="70" size="11914">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr8.sml?httpAccept=%2A%2F%2A</object><object ref="gr5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="122" size="8536">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr5.sml?httpAccept=%2A%2F%2A</object><object ref="sc1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2764" height="1827" size="406533">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-sc1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr6" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2567" height="1219" size="348865">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr9" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2961" height="2925" size="882803">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr9_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="3059" height="828" size="285319">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2370" height="1582" size="415419">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="fx1" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2213" height="881" size="384184">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-fx1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr7" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2862" height="2785" size="740043">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr7_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="3256" height="3047" size="1234419">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2370" height="1528" size="482565">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr8" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2370" height="753" size="295402">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr8_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="high" type="IMAGE-HIGH-RES" multimediatype="JPEG image file" mimetype="image/jpeg" width="2961" height="1644" size="521428">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-gr5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref="mmc1" category="standard" type="APPLICATION" multimediatype="Microsoft Word file" mimetype="application/word" size="19054714">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-mmc1.docx?httpAccept=%2A%2F%2A</object><object ref="am" category="standard" type="AAM-PDF" multimediatype="Acrobat PDF file" mimetype="application/pdf" size="1384479">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419303307-am.pdf?httpAccept=%2A%2F%2A</object></objects><scopus-id>85064854801</scopus-id><scopus-eid>2-s2.0-85064854801</scopus-eid><pubmed-id>31048139</pubmed-id><link href="https://api.elsevier.com/content/abstract/scopus_id/85064854801" rel="abstract"/></link><originalText><xocs:doc xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>271932</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291732</xocs:ssid>
         <xocs:ssid type="subj">291789</xocs:ssid>
         <xocs:ssid type="subj">291858</xocs:ssid>
         <xocs:ssid type="subj">291928</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>European Journal of Medicinal Chemistry</xocs:srctitle>
      <xocs:normalized-srctitle>EUROPEANJOURNALMEDICINALCHEMISTRY</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20190416">2019-04-16</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20190416">2019-04-16</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20190429">2019-04-29</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20190429">2019-04-29</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2020-02-04T20:44:24</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S0223523419303307</xocs:eid>
      <xocs:pii-formatted>S0223-5234(19)30330-7</xocs:pii-formatted>
      <xocs:pii-unformatted>S0223523419303307</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.ejmech.2019.04.024</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.3</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S0223523419X00112</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20200204">2020-02-04T21:54:58.834567Z</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20190715</xocs:date-search-begin>
      <xocs:year-nav>2019</xocs:year-nav>
      <xocs:indexeddate epoch="1555378342">2019-04-16T01:32:22.902951Z</xocs:indexeddate>
      <xocs:articleinfo>absattachment articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table e-component body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast footnotes grantnumber grantsponsor grantsponsorid highlightsabst orcid otherkwds primabst pubtype ref specialabst</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>0223-5234</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>02235234</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>174</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>174</xocs:volume>
      </xocs:volume-list>
      <xocs:suppl>C</xocs:suppl>
      <xocs:vol-iss-suppl-text>Volume 174</xocs:vol-iss-suppl-text>
      <xocs:sort-order>20</xocs:sort-order>
      <xocs:first-fp>236</xocs:first-fp>
      <xocs:last-lp>251</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>236</xocs:first-page>
         <xocs:last-page>251</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>20190715</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>15 July 2019</xocs:cover-date-text>
      <xocs:cover-date-start>2019-07-15</xocs:cover-date-start>
      <xocs:cover-date-year>2019</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Research paper</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>© 2019 Elsevier Masson SAS. All rights reserved.</xocs:copyright-line>
      <xocs:normalized-article-title>DISCOVERYFLUORESCENTCOUMARINBENZOBTHIOPHENE11DIOXIDECONJUGATESMITOCHONDRIATARGETINGANTITUMORSTAT3INHIBITORS</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>CAI</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>G</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Results and discussion</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Chemistry</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>In vitro cell growth inhibition activity</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound <ce:bold>7a</ce:bold> reduced colony formation <ce:italic>in vitro</ce:italic>
               </xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound <ce:bold>7a</ce:bold> induced apoptosis in cancer cells</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>
                  <ce:italic>Compound</ce:italic> 
                  <ce:bold>
                     <ce:italic>7a</ce:italic>
                  </ce:bold> 
                  <ce:italic>accumulated in mitochondria</ce:italic>
               </xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.6</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound <ce:bold>7a</ce:bold> affected the mitochondrial membrane potential (Δψ<ce:inf loc="post">m</ce:inf>)</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.7</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound <ce:bold>7a</ce:bold> induced the ROS generation in cancer cells</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.8</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound <ce:bold>7a</ce:bold> inhibited STAT3 tyrosine phosphorylation and serine phosphorylation</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.9</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound <ce:bold>7a</ce:bold> inhibited STAT3 DNA-binding activity</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.10</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound <ce:bold>7a</ce:bold> did not affect STAT1 phosphorylation and typical upstream or other kinases of STAT3</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.11</xocs:item-toc-label>
               <xocs:item-toc-section-title>Molecular docking study</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.12</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound <ce:bold>7a</ce:bold> affected the expression of STAT3 targeted genes</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.13</xocs:item-toc-label>
               <xocs:item-toc-section-title>Compound <ce:bold>7a</ce:bold> exhibited antitumor activity <ce:italic>in vivo</ce:italic>
               </xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Conclusions</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>4</xocs:item-toc-label>
            <xocs:item-toc-section-title>Materials and methods</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Chemistry</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>General procedures for the preparation of <ce:bold>2a</ce:bold>-<ce:bold>2n</ce:bold>
                  </xocs:item-toc-section-title>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.1</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 4-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2a</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.2</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 5-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2b</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.3</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 6-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2c</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.4</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 7-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2d</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.5</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 4-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2e</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.6</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 5-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2f</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.7</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 6-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2g</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.8</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 4-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2h</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.9</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 6-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2i</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.10</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 4-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2j</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.11</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 5-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2k</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.12</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 6-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2l</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.13</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 4-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2<ce:italic>m</ce:italic>
                        </ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.1.14</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Methyl 6-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2n</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>General procedures for the preparation of <ce:bold>3a</ce:bold>-<ce:bold>3n</ce:bold>
                  </xocs:item-toc-section-title>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.1</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3a</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.2</xocs:item-toc-label>
                     <xocs:item-toc-section-title>5-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3b</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.3</xocs:item-toc-label>
                     <xocs:item-toc-section-title>6-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3c</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.4</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3d</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.5</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3e</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.6</xocs:item-toc-label>
                     <xocs:item-toc-section-title>5-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3f</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.7</xocs:item-toc-label>
                     <xocs:item-toc-section-title>6-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3g</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.8</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3h</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.9</xocs:item-toc-label>
                     <xocs:item-toc-section-title>6-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3i</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.10</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3j</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.11</xocs:item-toc-label>
                     <xocs:item-toc-section-title>5-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3k</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.12</xocs:item-toc-label>
                     <xocs:item-toc-section-title>6-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3l</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.13</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3<ce:italic>m</ce:italic>
                        </ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.2.14</xocs:item-toc-label>
                     <xocs:item-toc-section-title>6-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3n</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>General procedures for the preparation of <ce:bold>4a</ce:bold>-<ce:bold>4o</ce:bold>
                  </xocs:item-toc-section-title>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.1</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(4-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4a</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.2</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(5-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4b</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.3</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(6-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4c</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.4</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(7-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4d</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.5</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(4-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4e</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.6</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(5-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4f</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.7</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(6-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4g</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.8</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(4-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4h</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.9</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(6-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4i</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.10</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(4-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4j</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.11</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(5-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4k</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.12</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(6-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4l</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.13</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(4-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4<ce:italic>m</ce:italic>
                        </ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.14</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(6-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4n</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.3.15</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(benzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4o</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>General procedures for the preparation of <ce:bold>5a</ce:bold>-<ce:bold>5o</ce:bold> and <ce:bold>8</ce:bold>
                  </xocs:item-toc-section-title>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.1</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(4-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5a</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.2</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(5-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5b</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.3</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(6-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5c</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.4</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(7-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5d</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.5</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(4-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5e</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.6</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(5-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5f</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.7</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(6-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5g</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.8</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(4-fluoro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5h</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.9</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4-(6-Fluoro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5i</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.10</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4-(4-Nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5j</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.11</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(5-nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5k</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.12</xocs:item-toc-label>
                     <xocs:item-toc-section-title>4-(6-Nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5l</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.13</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(4-methoxy-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5<ce:italic>m</ce:italic>
                        </ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.14</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(6-methoxy-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5n</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.15</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Tert-butyl 4-(1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5o</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.4.16</xocs:item-toc-label>
                     <xocs:item-toc-section-title>benzo[<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide (<ce:bold>8</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.5</xocs:item-toc-label>
                  <xocs:item-toc-section-title>General procedures for the preparation of <ce:bold>6</ce:bold>
                  </xocs:item-toc-section-title>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.5.1</xocs:item-toc-label>
                     <xocs:item-toc-section-title>Ethyl 7-(diethylamino)-2-oxo-2H-chromene-3-carboxylate</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.5.2</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-(diethylamino)-2-oxo-2H-chromene-3-carboxylic acid (6)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.6</xocs:item-toc-label>
                  <xocs:item-toc-section-title>General procedures for the preparation of <ce:bold>7a</ce:bold>-<ce:bold>7o</ce:bold>
                  </xocs:item-toc-section-title>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.1</xocs:item-toc-label>
                     <xocs:item-toc-section-title>3-(4-(4-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7a</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.2</xocs:item-toc-label>
                     <xocs:item-toc-section-title>3-(4-(5-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7b</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.3</xocs:item-toc-label>
                     <xocs:item-toc-section-title>3-(4-(6-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7c</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.4</xocs:item-toc-label>
                     <xocs:item-toc-section-title>3-(4-(7-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7d</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.5</xocs:item-toc-label>
                     <xocs:item-toc-section-title>3-(4-(4-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7e</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.6</xocs:item-toc-label>
                     <xocs:item-toc-section-title>3-(4-(5-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7f</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.7</xocs:item-toc-label>
                     <xocs:item-toc-section-title>3-(4-(6-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7g</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.8</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-(diethylamino)-3-(4-(4-fluoro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7h</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.9</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-(diethylamino)-3-(4-(6-fluoro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7i</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.10</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-(diethylamino)-3-(4-(4-nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7j</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.11</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-(diethylamino)-3-(4-(5-nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7k</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.12</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-(diethylamino)-3-(4-(6-nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7l</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.13</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-(diethylamino)-3-(4-(4-methoxy-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7<ce:italic>m</ce:italic>
                        </ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.14</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-(diethylamino)-3-(4-(6-methoxy-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7n</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
                  <xocs:item-toc-entry ref-elem="ce:sections">
                     <xocs:item-toc-label>4.1.6.15</xocs:item-toc-label>
                     <xocs:item-toc-section-title>7-(diethylamino)-3-(4-(1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7o</ce:bold>)</xocs:item-toc-section-title>
                  </xocs:item-toc-entry>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Cell line and cell culture</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Cell viability assays</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Colony forming assay</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>Cell apoptosis analysis</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.6</xocs:item-toc-label>
               <xocs:item-toc-section-title>Fluorescence colocalization</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.7</xocs:item-toc-label>
               <xocs:item-toc-section-title>Western blotting assays</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.8</xocs:item-toc-label>
               <xocs:item-toc-section-title>Electrophoretic mobility shift assay (EMSA) of DNA-binding activity</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.9</xocs:item-toc-label>
               <xocs:item-toc-section-title>Mitochondrial membrane potential detection</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.10</xocs:item-toc-label>
               <xocs:item-toc-section-title>ROS levels detection</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.11</xocs:item-toc-label>
               <xocs:item-toc-section-title>Molecular docking</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.12</xocs:item-toc-label>
               <xocs:item-toc-section-title>
                  <ce:italic>In vivo</ce:italic> tumor studies</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:appendices">
            <xocs:item-toc-label>Appendix A</xocs:item-toc-label>
            <xocs:item-toc-section-title>Supplementary data</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="sref1">
            <xocs:ref-normalized-surname>ABROUN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>395</xocs:ref-first-fp>
            <xocs:ref-last-lp>411</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref2">
            <xocs:ref-normalized-surname>BROMBERG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2000</xocs:ref-pub-year>
            <xocs:ref-first-fp>2468</xocs:ref-first-fp>
            <xocs:ref-last-lp>2473</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref3">
            <xocs:ref-normalized-surname>CARPENTER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>897</xocs:ref-first-fp>
            <xocs:ref-last-lp>925</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref4">
            <xocs:ref-normalized-surname>DARNELL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>1630</xocs:ref-first-fp>
            <xocs:ref-last-lp>1635</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref5">
            <xocs:ref-normalized-surname>LAUDISI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>1787</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref6">
            <xocs:ref-normalized-surname>BOWMAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2000</xocs:ref-pub-year>
            <xocs:ref-first-fp>2474</xocs:ref-first-fp>
            <xocs:ref-last-lp>2488</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref7">
            <xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>1181</xocs:ref-first-fp>
            <xocs:ref-last-lp>1191</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref8">
            <xocs:ref-normalized-surname>BEEBE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>74</xocs:ref-first-fp>
            <xocs:ref-last-lp>91</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref9">
            <xocs:ref-normalized-surname>BERNARDI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>687</xocs:ref-first-fp>
            <xocs:ref-last-lp>701</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref10">
            <xocs:ref-normalized-surname>DUCHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>365</xocs:ref-first-fp>
            <xocs:ref-last-lp>451</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref11">
            <xocs:ref-normalized-surname>GOGVADZE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>165</xocs:ref-first-fp>
            <xocs:ref-last-lp>173</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref12">
            <xocs:ref-normalized-surname>MCBRIDE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-first-fp>R551</xocs:ref-first-fp>
            <xocs:ref-last-lp>R560</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref13">
            <xocs:ref-normalized-surname>MODICANAPOLITANO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>755</xocs:ref-first-fp>
            <xocs:ref-last-lp>762</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref14">
            <xocs:ref-normalized-surname>TAIT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>807</xocs:ref-first-fp>
            <xocs:ref-last-lp>815</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref15">
            <xocs:ref-normalized-surname>GORRINI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>931</xocs:ref-first-fp>
            <xocs:ref-last-lp>947</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref16">
            <xocs:ref-normalized-surname>YE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>6353</xocs:ref-first-fp>
            <xocs:ref-last-lp>6363</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref17">
            <xocs:ref-normalized-surname>AGGARWAL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>59</xocs:ref-first-fp>
            <xocs:ref-last-lp>76</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref18">
            <xocs:ref-normalized-surname>AZNAR</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2001</xocs:ref-pub-year>
            <xocs:ref-first-fp>3282</xocs:ref-first-fp>
            <xocs:ref-last-lp>3294</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref19">
            <xocs:ref-normalized-surname>MACKENZIE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-article-number>e61532</xocs:ref-article-number>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref20">
            <xocs:ref-normalized-surname>MEIER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>20</xocs:ref-first-fp>
            <xocs:ref-last-lp>28</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref21">
            <xocs:ref-normalized-surname>YANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>532</xocs:ref-first-fp>
            <xocs:ref-last-lp>544</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref22">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>169</xocs:ref-first-fp>
            <xocs:ref-last-lp>182</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref23">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>31280</xocs:ref-first-fp>
            <xocs:ref-last-lp>31288</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Q</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref24">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>2237</xocs:ref-first-fp>
            <xocs:ref-last-lp>2244</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref25">
            <xocs:ref-normalized-surname>WEGRZYN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>793</xocs:ref-first-fp>
            <xocs:ref-last-lp>797</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref26">
            <xocs:ref-normalized-surname>GOUGH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>1713</xocs:ref-first-fp>
            <xocs:ref-last-lp>1716</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref27">
            <xocs:ref-normalized-surname>WEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1995</xocs:ref-pub-year>
            <xocs:ref-first-fp>241</xocs:ref-first-fp>
            <xocs:ref-last-lp>250</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref28">
            <xocs:ref-normalized-surname>ALONSO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2003</xocs:ref-pub-year>
            <xocs:ref-first-fp>3759</xocs:ref-first-fp>
            <xocs:ref-last-lp>3769</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref29">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>498</xocs:ref-first-fp>
            <xocs:ref-last-lp>507</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref30">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>195</xocs:ref-first-fp>
            <xocs:ref-last-lp>203</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref31">
            <xocs:ref-normalized-surname>JI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>1010</xocs:ref-first-fp>
            <xocs:ref-last-lp>1014</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref32">
            <xocs:ref-normalized-surname>SCHUST</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-first-fp>1235</xocs:ref-first-fp>
            <xocs:ref-last-lp>1242</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref33">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>46352</xocs:ref-first-fp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref34">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>538</xocs:ref-first-fp>
            <xocs:ref-last-lp>550</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref35">
            <xocs:ref-normalized-surname>JOKERST</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>1050</xocs:ref-first-fp>
            <xocs:ref-last-lp>1060</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref36">
            <xocs:ref-normalized-surname>AW</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>12586</xocs:ref-first-fp>
            <xocs:ref-last-lp>12601</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref37">
            <xocs:ref-normalized-surname>BARDHAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>936</xocs:ref-first-fp>
            <xocs:ref-last-lp>946</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref38">
            <xocs:ref-normalized-surname>HORI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>12360</xocs:ref-first-fp>
            <xocs:ref-last-lp>12365</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref39">
            <xocs:ref-normalized-surname>RONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>667</xocs:ref-first-fp>
            <xocs:ref-last-lp>669</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref40">
            <xocs:ref-normalized-surname>GUO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>2884</xocs:ref-first-fp>
            <xocs:ref-last-lp>2887</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref41">
            <xocs:ref-normalized-surname>XU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>5022</xocs:ref-first-fp>
            <xocs:ref-last-lp>5034</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref42">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>17415</xocs:ref-first-fp>
            <xocs:ref-last-lp>17421</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref43">
            <xocs:ref-normalized-surname>YAO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>1030</xocs:ref-first-fp>
            <xocs:ref-last-lp>1034</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref44">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>220</xocs:ref-first-fp>
            <xocs:ref-last-lp>227</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref45">
            <xocs:ref-normalized-surname>HUANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>887</xocs:ref-first-fp>
            <xocs:ref-last-lp>897</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref46">
            <xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2019</xocs:ref-pub-year>
            <xocs:ref-first-fp>543</xocs:ref-first-fp>
            <xocs:ref-last-lp>554</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref47">
            <xocs:ref-normalized-surname>SATURNINO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>112</xocs:ref-first-fp>
            <xocs:ref-last-lp>119</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref48">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>301</xocs:ref-first-fp>
            <xocs:ref-last-lp>310</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref49">
            <xocs:ref-normalized-surname>ZHOU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>39</xocs:ref-first-fp>
            <xocs:ref-last-lp>50</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>Q</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref50">
            <xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2016</xocs:ref-pub-year>
            <xocs:ref-first-fp>1006</xocs:ref-first-fp>
            <xocs:ref-last-lp>1018</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref51">
            <xocs:ref-normalized-surname>GUO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2018</xocs:ref-pub-year>
            <xocs:ref-first-fp>752</xocs:ref-first-fp>
            <xocs:ref-last-lp>764</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref52">
            <xocs:ref-normalized-surname>KROEMER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>99</xocs:ref-first-fp>
            <xocs:ref-last-lp>163</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref53">
            <xocs:ref-normalized-surname>DEMARIA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>1997</xocs:ref-first-fp>
            <xocs:ref-last-lp>2003</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref54">
            <xocs:ref-normalized-surname>CHUNG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>6508</xocs:ref-first-fp>
            <xocs:ref-last-lp>6516</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref55">
            <xocs:ref-normalized-surname>NAYAK</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2017</xocs:ref-pub-year>
            <xocs:ref-first-fp>1275</xocs:ref-first-fp>
            <xocs:ref-last-lp>1287</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref56">
            <xocs:ref-normalized-surname>HUANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2015</xocs:ref-pub-year>
            <xocs:ref-first-fp>17797</xocs:ref-first-fp>
            <xocs:ref-last-lp>17801</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>CAIX2019X236</xocs:refkey3>
         <xocs:refkey4lp>CAIX2019X236X251</xocs:refkey4lp>
         <xocs:refkey4ai>CAIX2019X236XG</xocs:refkey4ai>
         <xocs:refkey5>CAIX2019X236X251XG</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="0" is-open-archive="0"/></xocs:oa-article-status>
      </xocs:open-access>
      <xocs:open-research>
         <xocs:or-embargo-opening-date>2021-04-29T00:00:00.000Z</xocs:or-embargo-opening-date>
      </xocs:open-research>
      <xocs:self-archiving>
         <xocs:sa-start-date>2021-04-29T00:00:00.000Z</xocs:sa-start-date>
         <xocs:sa-user-license>http://creativecommons.org/licenses/by-nc-nd/4.0/</xocs:sa-user-license>
      </xocs:self-archiving>
      <xocs:copyright-info>
         <xocs:cp-notices>
            <xocs:cp-notice lang="en">© 2019 Elsevier Masson SAS. All rights reserved.</xocs:cp-notice>
         </xocs:cp-notices>
      </xocs:copyright-info>
      <xocs:funding-list has-funding-info="1">
         <xocs:funding-addon-generated-timestamp>2019-04-17T04:27:51.828Z</xocs:funding-addon-generated-timestamp>
         <xocs:funding-addon-type>http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/eoas</xocs:funding-addon-type>
         <xocs:funding>
            <xocs:funding-agency>Natural Science Research of Jiangsu Higher Education Institutions of China</xocs:funding-agency>
            <xocs:funding-agency-id>http://data.elsevier.com/vocabulary/SciValFunders/501100010023</xocs:funding-agency-id>
            <xocs:funding-agency-country>http://sws.geonames.org/1814991</xocs:funding-agency-country>
         </xocs:funding>
         <xocs:funding>
            <xocs:funding-agency>National Natural Science Foundation of China</xocs:funding-agency>
            <xocs:funding-agency-id>http://data.elsevier.com/vocabulary/SciValFunders/501100001809</xocs:funding-agency-id>
            <xocs:funding-agency-country>http://sws.geonames.org/1814991</xocs:funding-agency-country>
         </xocs:funding>
      </xocs:funding-list>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S0223-5234(19)30330-7</xocs:pii-formatted>
         <xocs:pii-unformatted>S0223523419303307</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S0223523419303307</xocs:eid>
         <xocs:doi>10.1016/j.ejmech.2019.04.024</xocs:doi>
         <xocs:cid>271932</xocs:cid>
         <xocs:timestamp>2020-02-04T21:54:58.834567Z</xocs:timestamp>
         <xocs:cover-date-start>2019-07-15</xocs:cover-date-start>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/MAIN/application/pdf/f33f8e356808f509523fa21e20c029c5/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>3164959</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>16</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S0223523419303307-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/PREVIEW/image/png/4ec9e16ce980deb10625be9fde89ba04/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>56546</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-sc1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/sc1/DOWNSAMPLED/image/jpeg/563098df04cbdb9155e1b1d83e916090/sc1.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>48997</xocs:filesize>
               <xocs:pixel-height>412</xocs:pixel-height>
               <xocs:pixel-width>624</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr6.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr6/DOWNSAMPLED/image/jpeg/d6d6bcfee66f18c66ddd3e84acce9c2b/gr6.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>40918</xocs:filesize>
               <xocs:pixel-height>275</xocs:pixel-height>
               <xocs:pixel-width>580</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr9.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr9/DOWNSAMPLED/image/jpeg/e6d34cc0c86e41a4e7b163f4971b8a00/gr9.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr9</xocs:file-basename>
               <xocs:filename>gr9.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>97380</xocs:filesize>
               <xocs:pixel-height>661</xocs:pixel-height>
               <xocs:pixel-width>669</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr2/DOWNSAMPLED/image/jpeg/88e519f5df10a1b10dba90b10952e59f/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>32573</xocs:filesize>
               <xocs:pixel-height>187</xocs:pixel-height>
               <xocs:pixel-width>691</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr1/DOWNSAMPLED/image/jpeg/fd4c791b539d0c3021ce60d653c3ee8d/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>50244</xocs:filesize>
               <xocs:pixel-height>357</xocs:pixel-height>
               <xocs:pixel-width>535</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-fx1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/fx1/DOWNSAMPLED/image/jpeg/277177ebe5d3e4b3f45d1c166f874740/fx1.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>44050</xocs:filesize>
               <xocs:pixel-height>199</xocs:pixel-height>
               <xocs:pixel-width>500</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr7.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr7/DOWNSAMPLED/image/jpeg/d1263ff5dd05947b4f3786cce67c5f2b/gr7.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>84156</xocs:filesize>
               <xocs:pixel-height>629</xocs:pixel-height>
               <xocs:pixel-width>646</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr3/DOWNSAMPLED/image/jpeg/bf32f1609711f4594891dd291b21c1eb/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>131007</xocs:filesize>
               <xocs:pixel-height>688</xocs:pixel-height>
               <xocs:pixel-width>735</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr4/DOWNSAMPLED/image/jpeg/55a28948559ea1573966b0fe755e123b/gr4.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>50244</xocs:filesize>
               <xocs:pixel-height>345</xocs:pixel-height>
               <xocs:pixel-width>535</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr8.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr8/DOWNSAMPLED/image/jpeg/9a3f9470a53fba448e25310b4ecdad8d/gr8.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>33437</xocs:filesize>
               <xocs:pixel-height>170</xocs:pixel-height>
               <xocs:pixel-width>535</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr5/DOWNSAMPLED/image/jpeg/99b5ea9c82b036459764ab1340858487/gr5.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>58832</xocs:filesize>
               <xocs:pixel-height>371</xocs:pixel-height>
               <xocs:pixel-width>669</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-sc1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/sc1/THUMBNAIL/image/gif/6b6e9b14973e7a63d11b252d775ee329/sc1.sml</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>6174</xocs:filesize>
               <xocs:pixel-height>145</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr6.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr6/THUMBNAIL/image/gif/b26021c4f4d5665aa0f467bfe8ebecf6/gr6.sml</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>7157</xocs:filesize>
               <xocs:pixel-height>104</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr9.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr9/THUMBNAIL/image/gif/67606d42ccc82c770a2b5829ac6032a7/gr9.sml</xocs:ucs-locator>
               <xocs:file-basename>gr9</xocs:file-basename>
               <xocs:filename>gr9.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>11272</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>166</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr2/THUMBNAIL/image/gif/99e12f8c141879d6cfdf0bbd48e071d5/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>8352</xocs:filesize>
               <xocs:pixel-height>59</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr1/THUMBNAIL/image/gif/cece22f6249cc9c8ec8da2aef7fc7ad7/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>7302</xocs:filesize>
               <xocs:pixel-height>146</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-fx1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/fx1/THUMBNAIL/image/gif/338232634da4b224d46f8ecaf5afb7b8/fx1.sml</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>11552</xocs:filesize>
               <xocs:pixel-height>87</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr7.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr7/THUMBNAIL/image/gif/57937c5899251f3d92b24ebebdb4e4c1/gr7.sml</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>10353</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>168</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr3/THUMBNAIL/image/gif/10a7ed9b56025143fecda99e88ee2d4e/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>10645</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>175</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr4/THUMBNAIL/image/gif/e7087e345cee25acaaae5608f80caba1/gr4.sml</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>17179</xocs:filesize>
               <xocs:pixel-height>141</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr8.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr8/THUMBNAIL/image/gif/247fc645be108fbb5eb34c5f14f54af8/gr8.sml</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>11914</xocs:filesize>
               <xocs:pixel-height>70</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr5/THUMBNAIL/image/gif/7988c7dd4493239a375a9e33b971e090/gr5.sml</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>8536</xocs:filesize>
               <xocs:pixel-height>122</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-sc1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/sc1/HIGHRES/image/jpeg/461532fa4531c100e58a01793fddba76/sc1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>sc1</xocs:file-basename>
               <xocs:filename>sc1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>406533</xocs:filesize>
               <xocs:pixel-height>1827</xocs:pixel-height>
               <xocs:pixel-width>2764</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr6_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr6/HIGHRES/image/jpeg/750fafe14eadfa97672b4fe2f73c729e/gr6_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>348865</xocs:filesize>
               <xocs:pixel-height>1219</xocs:pixel-height>
               <xocs:pixel-width>2567</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr9_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr9/HIGHRES/image/jpeg/589df05eb9eee6ccc4127d0f8d22e308/gr9_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr9</xocs:file-basename>
               <xocs:filename>gr9_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>882803</xocs:filesize>
               <xocs:pixel-height>2925</xocs:pixel-height>
               <xocs:pixel-width>2961</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr2_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr2/HIGHRES/image/jpeg/046248999ae2985c711d82e55c513078/gr2_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>285319</xocs:filesize>
               <xocs:pixel-height>828</xocs:pixel-height>
               <xocs:pixel-width>3059</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr1/HIGHRES/image/jpeg/6c1cb2514db364828814ab04aa71750b/gr1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>415419</xocs:filesize>
               <xocs:pixel-height>1582</xocs:pixel-height>
               <xocs:pixel-width>2370</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-fx1_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/fx1/HIGHRES/image/jpeg/633396467fe9db0b1977c3df1f2e8373/fx1_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>384184</xocs:filesize>
               <xocs:pixel-height>881</xocs:pixel-height>
               <xocs:pixel-width>2213</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr7_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr7/HIGHRES/image/jpeg/13156f156683fb86b6f8eb1d08bbcc3b/gr7_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>740043</xocs:filesize>
               <xocs:pixel-height>2785</xocs:pixel-height>
               <xocs:pixel-width>2862</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr3_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr3/HIGHRES/image/jpeg/176b6db17ca95809301bb058ca1d72d9/gr3_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>1234419</xocs:filesize>
               <xocs:pixel-height>3047</xocs:pixel-height>
               <xocs:pixel-width>3256</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr4_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr4/HIGHRES/image/jpeg/1650529c268794e1c884434e20c19e13/gr4_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>482565</xocs:filesize>
               <xocs:pixel-height>1528</xocs:pixel-height>
               <xocs:pixel-width>2370</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr8_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr8/HIGHRES/image/jpeg/22755d33c45619bdbf5a75572060b050/gr8_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr8</xocs:file-basename>
               <xocs:filename>gr8_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>295402</xocs:filesize>
               <xocs:pixel-height>753</xocs:pixel-height>
               <xocs:pixel-width>2370</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-gr5_lrg.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/gr5/HIGHRES/image/jpeg/e0c008d72cb0e6510aff616c0b22a26a/gr5_lrg.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5_lrg.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>521428</xocs:filesize>
               <xocs:pixel-height>1644</xocs:pixel-height>
               <xocs:pixel-width>2961</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-mmc1.docx</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523419303307/mmc1/MAIN/application/vnd.openxmlformats-officedocument.wordprocessingml.document/d921ec6c582731e0f4972209cbc895a9/mmc1.docx</xocs:ucs-locator>
               <xocs:file-basename>mmc1</xocs:file-basename>
               <xocs:filename>mmc1.docx</xocs:filename>
               <xocs:extension>docx</xocs:extension>
               <xocs:filesize>19054714</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523419303307-am.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/egi:10CB65H58HJ/MAIN/application/pdf/0b5c2c02223d3f15fdcefa9d1c9de7cf/am.pdf</xocs:ucs-locator>
               <xocs:file-basename>am</xocs:file-basename>
               <xocs:filename>am.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>false</xocs:pdf-optimized>
               <xocs:filesize>1384479</xocs:filesize>
               <xocs:attachment-type>AAM-PDF</xocs:attachment-type>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta><xocs:serial-item xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" docsubtype="fla" version="5.5" xml:lang="en">
         <item-info>
            <jid>EJMECH</jid>
            <aid>11259</aid>
            <ce:pii>S0223-5234(19)30330-7</ce:pii>
            <ce:doi>10.1016/j.ejmech.2019.04.024</ce:doi>
            <ce:copyright type="full-transfer" year="2019">Elsevier Masson SAS</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="fig1">
               <ce:label>Fig. 1</ce:label>
               <ce:caption id="cap0010">
                  <ce:simple-para id="fspara0010" view="all">Design strategy of the coumarin-benzo [<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide conjugates for targeting mitochondria and tumor therapy.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0015">Fig. 1</ce:alt-text>
               <ce:link locator="gr1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/gr1"/></ce:link>
            </ce:figure>
            <ce:figure id="fig2">
               <ce:label>Fig. 2</ce:label>
               <ce:caption id="cap0015">
                  <ce:simple-para id="fspara0015" view="all">
                     <ce:bold>Compound 7a inhibited MDA-MB-231 cells proliferation <ce:italic>in vitro</ce:italic>.</ce:bold> MDA-MB-231 cells were treated with compound <ce:bold>7a</ce:bold> at tested concentrations for 24 h. Cells were subcultured to fresh medium and allowed to grow until the colonies were visible.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0020">Fig. 2</ce:alt-text>
               <ce:link locator="gr2" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/gr2"/></ce:link>
            </ce:figure>
            <ce:figure id="fig3">
               <ce:label>Fig. 3</ce:label>
               <ce:caption id="cap0020">
                  <ce:simple-para id="fspara0020" view="all">
                     <ce:bold>Apoptotic effects of compound 7a on MDA-MB-231 cells.</ce:bold> MDA-MB-231 cells were treated with compound <ce:bold>7a</ce:bold> at tested concentrations for 24 h. (A) Apoptotic effects were detected using Annexin V-FITC/PI staining by flow cytometry. (B) The histograms for % of apoptosis (early and late stages of apoptosis). ***, p < 0.001, **, p < 0.01. (C) The effects of compound <ce:bold>7a</ce:bold> on protein levels of Caspase-9, Cleaved Caspase-9, Caspase-3, Cleaved Caspase-3, PARP and Cleaved PARP. Cell lysates were harvested and analyzed using the corresponding antibodies by western blotting. (D) Quantitative analysis of western blotting by Image Lab program with GAPDH as the internal control. ***, p < 0.001. **, p < 0.01.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0025">Fig. 3</ce:alt-text>
               <ce:link locator="gr3" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/gr3"/></ce:link>
            </ce:figure>
            <ce:figure id="fig4">
               <ce:label>Fig. 4</ce:label>
               <ce:caption id="cap0025">
                  <ce:simple-para id="fspara0025" view="all">
                     <ce:bold>Subcellular localization studies of compound 7a in MDA-MB-231 cells and MCF-7 cells.</ce:bold> Images of cells pretreated, respectively, with compound <ce:bold>7a</ce:bold> for 60 min, and subsequently, 1 μM MitoTracker Red (<ce:cross-ref refid="fig4" id="crosref0355">Fig. 4</ce:cross-ref>b) or 1 μM LysoTracker Red <ce:cross-ref refid="appsec1" id="crosref0360">(Fig. S2b in the Supporting Information)</ce:cross-ref> for 30 min. (a) Probe fluorescence, blue channel; (b) MitoTracker, red channel; (c) The overlap.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0030">Fig. 4</ce:alt-text>
               <ce:link locator="gr4" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/gr4"/></ce:link>
            </ce:figure>
            <ce:figure id="fig5">
               <ce:label>Fig. 5</ce:label>
               <ce:caption id="cap0030">
                  <ce:simple-para id="fspara0030" view="all">
                     <ce:bold>Compound 7a affected mitochondrial membrane potential in MDA-MB-231 cells.</ce:bold> (A) MDA-MB-231 cells were treated with compound <ce:bold>7a</ce:bold> at tested concentrations for 24 h analyzed using flow cytometer after JC-1 staining. (B) The ratios of red fluorescence to green fluorescence. **, p < 0.01, ***, p < 0.001.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0035">Fig. 5</ce:alt-text>
               <ce:link locator="gr5" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/gr5"/></ce:link>
            </ce:figure>
            <ce:figure id="fig6">
               <ce:label>Fig. 6</ce:label>
               <ce:caption id="cap0035">
                  <ce:simple-para id="fspara0035" view="all">
                     <ce:bold>Compound 7a induced ROS generation.</ce:bold> MDA-MB-231 cells were treated with compound <ce:bold>7a</ce:bold> at tested concentrations for 24 h. (A) The ROS accumulation in MDA-MB-231 cells measured by flow cytometer using DCFH-DA staining. (B) Relative ROS levels of MDA-MB-231 cells after treatment with compound <ce:bold>7a</ce:bold> for 24 h *, p < 0.05, **, p < 0.01.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0040">Fig. 6</ce:alt-text>
               <ce:link locator="gr6" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/gr6"/></ce:link>
            </ce:figure>
            <ce:figure id="fig7">
               <ce:label>Fig. 7</ce:label>
               <ce:caption id="cap0040">
                  <ce:simple-para id="fspara0040" view="all">
                     <ce:bold>Compound 7a inhibited STAT3 activation and the effects of compound 7a on protein levels of STAT3 related proteins.</ce:bold> MDA-MB-231 cells were treated with compound <ce:bold>7a</ce:bold> at tested concentrations for 24 h and then the cell lysates were harvested and analyzed using the corresponding antibodies by western blotting or EMSA analysis. (A) The effects of compound <ce:bold>7a</ce:bold> on STAT3, p-STAT3 (Y705), p-STAT3 (S727), STAT1 and p-STAT1 (Y701) protein levels in MDA-MB-231 cells by western blotting analysis using GAPDH as a control. (B) EMSA analysis of nuclear extracts of equal total protein containing activated STAT3 from MDA-MB-231 cells treated with compound <ce:bold>7a</ce:bold> or <ce:bold>Stattic</ce:bold> for 24 h after incubation with hSIE probe that binds STAT3. (C) The effects of compound <ce:bold>7a</ce:bold> on protein levels of upstream tyrosine kinases <ce:italic>p</ce:italic>-JAK2, Src, <ce:italic>p</ce:italic>-Src and bypass tyrosine kinase Erk1/2 and <ce:italic>p</ce:italic>-Erk1/2. (D) The effects of compound <ce:bold>7a</ce:bold> on expression levels of STAT3 related downstream gene Bcl-2 and Cyclin D1 and the quantitative analysis of western blotting by Image Lab program with GAPDH as the internal control. **, p < 0.01, ***, p < 0.001.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0045">Fig. 7</ce:alt-text>
               <ce:link locator="gr7" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/gr7"/></ce:link>
            </ce:figure>
            <ce:figure id="fig8">
               <ce:label>Fig. 8</ce:label>
               <ce:caption id="cap0045">
                  <ce:simple-para id="fspara0045" view="all">
                     <ce:bold>Molecular docking model of compound 7a binding to SH2 domain of STAT3 generated by Autodock 4.2.</ce:bold> (A) Carbon atoms of compound <ce:bold>7a</ce:bold> were colored magenta. STAT3 protein was represented as white ribbon and the key residues were shown. Hydrogen bonds were represented by green lines. (B) Compound <ce:bold>7a</ce:bold> bound to hot spot pTyr705 site and side pocket of STAT3 SH2 domain (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.).</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0050">Fig. 8</ce:alt-text>
               <ce:link locator="gr8" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/gr8"/></ce:link>
            </ce:figure>
            <ce:figure id="fig9">
               <ce:label>Fig. 9</ce:label>
               <ce:caption id="cap0050">
                  <ce:simple-para id="fspara0050" view="all">
                     <ce:bold>Compound 7a inhibited the growth of mouse sarcoma xenograft tumors <ce:italic>in vivo</ce:italic>.</ce:bold> (A) The weight of tumor tissues of control and treated mice. (B) The tumor growth inhibitory rates of compound <ce:bold>7a</ce:bold> (10 mg/kg, 20 mg/kg). (C) The growing curves of mice's tumor volume. (D) Anatomical mice's tumor tissue untreated or treated with compound <ce:bold>7a</ce:bold> (10 mg/kg, 20 mg/kg). (E) Western blotting analysis of p-STAT3 (Y705) and STAT3 levels in tumor tissues prepared from control or mice treated with compound <ce:bold>7a</ce:bold> (10 mg/kg, 20 mg/kg). **, p < 0.01, ***, p < 0.001.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0055">Fig. 9</ce:alt-text>
               <ce:link locator="gr9" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/gr9"/></ce:link>
            </ce:figure>
            <ce:figure id="sch1">
               <ce:label>Scheme 1</ce:label>
               <ce:caption id="cap0055">
                  <ce:simple-para id="fspara0055" view="all">Synthesis of fluorescent coumarin-benzo [<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide conjugates compound <ce:bold>7a-7o</ce:bold>. Reagents and conditions: (a) HSCH<ce:inf loc="post">2</ce:inf>COOCH<ce:inf loc="post">3</ce:inf>, DMF, 60 °C, 15 h; (b) 10% KOH, reflux, 3 h, 1 M HCl; (c) tert-butyl-1-piperazine-carboxylate, HATU, DIEA, DCM, rt., 12 h; (d) <ce:italic>m</ce:italic>-CPBA, DCM, 45 °C, 5 h; (e) (i) TFA, DCM, rt., 2 h; (ii) HATU, DIEA, DCM, rt., 12 h.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0060">Scheme 1</ce:alt-text>
               <ce:link locator="sc1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/sc1"/></ce:link>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl1" frame="topbot" colsep="0" rowsep="0">
               <ce:label>Table 1</ce:label>
               <ce:caption id="cap0060">
                  <ce:simple-para id="tspara0010" view="all">Anti-proliferative activity of the designed compounds <ce:bold>7a-7o</ce:bold>, compound <ce:bold>8</ce:bold> and the reference compound <ce:bold>Stattic</ce:bold>.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0065">Table 1</ce:alt-text>
               <tgroup cols="6">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <colspec colnum="5" colname="col5"/></colspec>
                  <colspec colnum="6" colname="col6"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1">Compd.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" morerows="1">R</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" namest="col3" nameend="col6">IC<inf loc="post">50</inf> ± SD (μM)<cross-ref refid="tbl1fna" id="crosref0365">
                              <sup loc="post">a</sup>
                           </cross-ref>
                        </entry>
                     </row>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">MDA-MB-231</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">HCT-116</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">HepG2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">MCF-7</entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4-Br</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.43 ± 0.30</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.89 ± 0.42</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.88 ± 0.69</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.33 ± 0.23</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7b</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5-Br</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.23 ± 0.12</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.83 ± 0.79</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.15 ± 1.00</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.90 ± 0.31</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7c</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6-Br</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.74 ± 0.37</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.79 ± 0.41</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.52 ± 0.89</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.04 ± 0.76</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7d</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">7-Br</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.32 ± 0.19</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.97 ± 0.62</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.74 ± 0.77</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.20 ± 0.32</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7e</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4-Cl</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.24 ± 0.08</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.57 ± 0.05</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.49 ± 0.46</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.44 ± 0.31</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7f</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5-Cl</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.35 ± 0.16</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.12 ± 0.60</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.55 ± 0.89</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.39 ± 0.91</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7g</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6-Cl</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.03 ± 0.09</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.44 ± 0.66</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.29 ± 0.56</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.23 ± 0.41</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7h</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4-F</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.13 ± 0.28</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.33 ± 0.42</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.30 ± 0.11</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.04 ± 0.60</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7i</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6-F</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.20 ± 0.31</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.26 ± 0.73</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.90 ± 1.25</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.35 ± 0.64</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7j</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4-NO<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.46 ± 0.28</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.24 ± 0.30</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.91 ± 0.10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.41 ± 0.60</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7k</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5-NO<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.92 ± 0.41</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.74 ± 1.10</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">7.47 ± 0.92</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.33 ± 0.68</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7l</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6-NO<inf loc="post">2</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.22 ± 0.30</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.95 ± 0.39</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">7.09 ± 0.12</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.76 ± 0.57</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7<italic>m</italic>
                           </bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4-OCH<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.84 ± 0.16</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.02 ± 0.15</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.94 ± 0.12</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.95 ± 0.80</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7n</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6-OCH<inf loc="post">3</inf>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.92 ± 0.22</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.30 ± 0.13</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.21 ± 0.95</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.28 ± 0.13</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7o</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">H</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.32 ± 0.21</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.78 ± 0.37</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">4.31 ± 0.76</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.00 ± 0.23</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>8</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/></entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">27.65 ± 8.93</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">9.33 ± 1.64</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">22.87 ± 4.90</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">15.19 ± 2.18</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>Stattic</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/></entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.81 ± 0.21</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">2.16 ± 0.06</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.52 ± 0.79</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.71 ± 0.19</entry>
                     </row>
                  </tbody>
               </tgroup>
               <ce:table-footnote id="tbl1fna">
                  <ce:label>a</ce:label>
                  <ce:note-para id="ntpara0015" view="all">The inhibitory effects of individual compounds on the proliferation of the four cell lines were determined by the MTT assay. SD: standard deviation, all experiments were independently performed at least three times.</ce:note-para>
               </ce:table-footnote>
            </ce:table>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl2" frame="topbot" colsep="0" rowsep="0">
               <ce:label>Table 2</ce:label>
               <ce:caption id="cap0065">
                  <ce:simple-para id="tspara0015" view="all">Anti-proliferative activity and selectivity index of compound <ce:bold>7a</ce:bold> and <ce:bold>Stattic</ce:bold> on MCF-10 A and L02 cells.</ce:simple-para>
               </ce:caption>
               <ce:alt-text role="short" id="alttext0070">Table 2</ce:alt-text>
               <tgroup cols="5">
                  <colspec colnum="1" colname="col1"/></colspec>
                  <colspec colnum="2" colname="col2"/></colspec>
                  <colspec colnum="3" colname="col3"/></colspec>
                  <colspec colnum="4" colname="col4"/></colspec>
                  <colspec colnum="5" colname="col5"/></colspec>
                  <thead>
                     <row rowsep="1" valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Compd.</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">IC<inf loc="post">50</inf> ± SD (μM)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Selectivity Index IC<inf loc="post">50</inf> (MCF-10 A)/IC<inf loc="post">50</inf> (MDA-MB-231)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd">Selectivity Index IC<inf loc="post">50</inf> (L02)/IC<inf loc="post">50</inf> (HepG2)</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/></entry>
                     </row>
                  </thead>
                  <tbody>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/></entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">MCF-10 A</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">L02</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/></entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd"/></entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>7a</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">14.62 ± 1.14</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">35.60 ± 0.81</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">10.2</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">12.4</entry>
                     </row>
                     <row valign="top">
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">
                           <bold>Stattic</bold>
                        </entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">6.11 ± 0.18</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">5.20 ± 0.32</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">3.4</entry>
                        <entry xmlns="http://www.elsevier.com/xml/common/dtd" align="left">1.5</entry>
                     </row>
                  </tbody>
               </tgroup>
            </ce:table>
         </ce:floats>
         <head>
            <ce:dochead id="dhead0010">
               <ce:textfn>Research paper</ce:textfn>
            </ce:dochead>
            <ce:title id="title0010">Discovery of fluorescent coumarin-benzo[<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors</ce:title>
            <ce:author-group id="augrp0010">
               <ce:author id="au1" author-id="S0223523419303307-5be36facd87d1e221d5eee5734db4b01">
                  <ce:given-name>Guiping</ce:given-name>
                  <ce:surname>Cai</ce:surname>
                  <ce:cross-ref refid="fn1" id="crosref0010">
                     <ce:sup loc="post">1</ce:sup>
                  </ce:cross-ref>
               </ce:author>
               <ce:author id="au2" author-id="S0223523419303307-d1cf9a947be835fd95e9f5d003e1151d">
                  <ce:given-name>Wenying</ce:given-name>
                  <ce:surname>Yu</ce:surname>
                  <ce:cross-ref refid="cor2" id="crosref0015">
                     <ce:sup loc="post">∗∗</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="fn1" id="crosref0020">
                     <ce:sup loc="post">1</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au3" author-id="S0223523419303307-61fec636af7345d4cf82ee563c84d6c8">
                  <ce:given-name>Dongmei</ce:given-name>
                  <ce:surname>Song</ce:surname>
               </ce:author>
               <ce:author id="au4" author-id="S0223523419303307-2e90297f20cc85a4bba96283317d4b1d">
                  <ce:given-name>Wenda</ce:given-name>
                  <ce:surname>Zhang</ce:surname>
               </ce:author>
               <ce:author id="au5" author-id="S0223523419303307-ff1b91ef1962d9c0f1403f22a5d49a4d">
                  <ce:given-name>Jianpeng</ce:given-name>
                  <ce:surname>Guo</ce:surname>
               </ce:author>
               <ce:author id="au6" author-id="S0223523419303307-6057e4b0917dfd43e6326c21189fa489">
                  <ce:given-name>Jiawen</ce:given-name>
                  <ce:surname>Zhu</ce:surname>
               </ce:author>
               <ce:author id="au7" author-id="S0223523419303307-62f06b828f08336c7526fb98b9ccc7d9">
                  <ce:given-name>Yuhao</ce:given-name>
                  <ce:surname>Ren</ce:surname>
               </ce:author>
               <ce:author id="au8" orcid="0000-0002-4791-8615" author-id="S0223523419303307-6dcd0171bf7f28d6f49075140d5a7fe1">
                  <ce:given-name>Lingyi</ce:given-name>
                  <ce:surname>Kong</ce:surname>
                  <ce:cross-ref refid="cor1" id="crosref0025">
                     <ce:sup loc="post">∗</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:affiliation id="aff1" affiliation-id="S0223523419303307-f655215a5e6df9542628aeba6cef41c0">
                  <ce:textfn>Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing, 210009, PR China</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines</sa:organization>
                     <sa:organization>China Pharmaceutical University</sa:organization>
                     <sa:address-line>24 Tong Jia Xiang</sa:address-line>
                     <sa:city>Nanjing</sa:city>
                     <sa:postal-code>210009</sa:postal-code>
                     <sa:country>PR China</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:correspondence id="cor1">
                  <ce:label>∗</ce:label>
                  <ce:text>Corresponding author.</ce:text>
               </ce:correspondence>
               <ce:correspondence id="cor2">
                  <ce:label>∗∗</ce:label>
                  <ce:text>Corresponding author.</ce:text>
               </ce:correspondence>
               <ce:footnote id="fn1">
                  <ce:label>1</ce:label>
                  <ce:note-para id="ntpara0010" view="all">Both authors contributed equally to this paper.</ce:note-para>
               </ce:footnote>
            </ce:author-group>
            <ce:date-received day="30" month="1" year="2019"/></ce:date-received>
            <ce:date-revised day="18" month="3" year="2019"/></ce:date-revised>
            <ce:date-accepted day="10" month="4" year="2019"/></ce:date-accepted>
            <ce:abstract xml:lang="en" id="abs0010" view="all" class="author"><ce:abstract-sec id="abssec0010" view="all">
                  <ce:simple-para id="abspara0010" view="all">STAT3 has been extensively studied as a potential antitumor target. Though studies on regulating STAT3 mainly focus on the inhibition of STAT3 phosphorylation at Tyr705 residue, the phosphorylation at Ser727 residue of STAT3 protein is also closely associated with the mitochondrial import of STAT3 protein. <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin is a fluorescent mitochondria-targeting probe. In this study, a series of STAT3 inhibitors were developed by connecting <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin fluorophore with benzo [<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide moiety. All designed compounds displayed potent anti-proliferative activity against cancer cells. The representative compound <ce:bold>7a</ce:bold> was mainly accumulated in mitochondria visualized by its fluorescence. STAT3 phosphorylation was inhibited by compound <ce:bold>7a</ce:bold> at both Tyr705 and Ser727 residues. Compound <ce:bold>7a</ce:bold> inhibited STAT3 phosphorylation whereas had no influence on the phosphorylation levels of STAT1, JAK2, Src and Erk1/2, indicating good selectivity of compound <ce:bold>7a</ce:bold>. Moreover, compound <ce:bold>7a</ce:bold> down-regulated the expression of STAT3 target genes Bcl-2 and Cyclin D1, increased ROS production and remarkably reduced the mitochondrial membrane potential to induce mitochondrial apoptotic pathway. Furthermore, compound <ce:bold>7a</ce:bold> 
                     <ce:italic>in vivo</ce:italic> suppressed breast cancer 4T1 implanted tumor growth. Taken together, these results highlighted that compound <ce:bold>7a</ce:bold> might be a promising mitochondria-targeting STAT3 inhibitor for cancer therapy.</ce:simple-para>
               </ce:abstract-sec></ce:abstract>
            <ce:abstract class="graphical" id="abs0015" view="all">
               <ce:section-title id="sectitle0015">Graphical abstract</ce:section-title>
               <ce:abstract-sec id="abssec0015" view="all">
                  <ce:simple-para id="abspara0015" view="all">Compound <ce:bold>7a</ce:bold> acted as a mitochondria-targeting STAT3 inhibitor to exert antitumor activities <ce:italic>in vitro</ce:italic> and <ce:italic>in vivo</ce:italic>.<ce:display>
                        <ce:figure id="undfig1">
                           <ce:alt-text role="short" id="alttext0010">Image 1</ce:alt-text>
                           <ce:link locator="fx1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:href="pii:S0223523419303307/fx1"/></ce:link>
                        </ce:figure>
                     </ce:display>
                  </ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            
            <ce:keywords xml:lang="en" id="kwrds0010" view="all" class="keyword">
               <ce:section-title id="sectitle0025">Keywords</ce:section-title>
               <ce:keyword id="kwrd0010">
                  <ce:text>STAT3</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0015">
                  <ce:text>Benzo[<ce:italic>b</ce:italic>]thiophene 1, 1-Dioxide</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0030">
                  <ce:text>
                     <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-Diethyl-7-aminocoumarin fluorophore</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0035">
                  <ce:text>Ser727 phosphorylation</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0040">
                  <ce:text>Mitochondrial apoptosis pathway</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0045">
                  <ce:text>Antitumor activity</ce:text>
               </ce:keyword>
            </ce:keywords>
            <ce:keywords xml:lang="en" class="abr" id="kwrds0015" view="all">
               <ce:section-title id="sectitle0030">Abbreviations</ce:section-title>
               <ce:keyword id="kwrd0050">
                  <ce:text>MTT</ce:text>
                  <ce:keyword id="kwrd0055">
                     <ce:text>3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0060">
                  <ce:text>STAT</ce:text>
                  <ce:keyword id="kwrd0065">
                     <ce:text>signal transducer and activator of transcription</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0070">
                  <ce:text>JC-1</ce:text>
                  <ce:keyword id="kwrd0075">
                     <ce:text>5,5ʹ,6,6ʹ-tetrachloro-1,1ʹ,3,3ʹ-tetraethyl-imidacarbocyanine iodide</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0080">
                  <ce:text>ROS</ce:text>
                  <ce:keyword id="kwrd0085">
                     <ce:text>reactive oxygen species</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0090">
                  <ce:text>JAK2</ce:text>
                  <ce:keyword id="kwrd0095">
                     <ce:text>Janus kinase 2</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0100">
                  <ce:text>Src</ce:text>
                  <ce:keyword id="kwrd0105">
                     <ce:text>steroid receptor coactivator</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0110">
                  <ce:text>Erk</ce:text>
                  <ce:keyword id="kwrd0115">
                     <ce:text>extracellular regulated kinase</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0120">
                  <ce:text>GAPDH</ce:text>
                  <ce:keyword id="kwrd0125">
                     <ce:text>glyceraldehyde-3-phosphatedehydrogenase</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0130">
                  <ce:text>SH2</ce:text>
                  <ce:keyword id="kwrd0135">
                     <ce:text>Src homology 2</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0140">
                  <ce:text>PI</ce:text>
                  <ce:keyword id="kwrd0145">
                     <ce:text>propidium iodide</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0150">
                  <ce:text>TMS</ce:text>
                  <ce:keyword id="kwrd0155">
                     <ce:text>tetramethylsilane</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0160">
                  <ce:text>PBS</ce:text>
                  <ce:keyword id="kwrd0165">
                     <ce:text>phosphate buffered saline</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0170">
                  <ce:text>FBS</ce:text>
                  <ce:keyword id="kwrd0175">
                     <ce:text>fetal bovine serum</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0180">
                  <ce:text>DMSO</ce:text>
                  <ce:keyword id="kwrd0185">
                     <ce:text>dimethyl sulfoxide</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0190">
                  <ce:text>rt.</ce:text>
                  <ce:keyword id="kwrd0195">
                     <ce:text>room temperature.</ce:text>
                  </ce:keyword>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="sec1" role="introduction" view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title id="sectitle0035">Introduction</ce:section-title>
                  <ce:para id="p0035" view="all">Signal transducer and activator of transcription 3 (STAT3), a latent cytoplasmic transcription factor, has been documented to play vital roles in a series of biological processes, such as cell proliferation, differentiation, development, survival, apoptosis and immunization [<ce:cross-refs refid="bib1 bib2 bib3 bib4 bib5" id="crosrefs0010">1–5</ce:cross-refs>]. Persistent activation of STAT3 by cytokines or growth factors exists in many solid and hematopoietic malignancies [<ce:cross-refs refid="bib5 bib6 bib7 bib8" id="crosrefs0015">5–8</ce:cross-refs>], making it a promising target for cancer therapy.</ce:para>
                  <ce:para id="p0040" view="all">As the powerhouse of cells and important intracellular organelles, mitochondria exert both crucial and lethal functions in physiological and pathological processes that generate metabolic energy <ce:italic>via</ce:italic> oxidative phosphorylation, maintain calcium homeostasis, produce cellular signaling by reactive oxygen species (ROS) and regulate the intrinsic pathway of apoptosis [<ce:cross-refs refid="bib9 bib10 bib11 bib12 bib13 bib14" id="crosrefs0020">9–14</ce:cross-refs>]. High level of ROS irreversibly results in DNA damage and ultimately causes apoptosis and necrosis of cancer cell [<ce:cross-ref refid="bib15" id="crosref0030">15</ce:cross-ref>]. And changes in mitochondrial membrane potential (Δ<ce:italic>ψ</ce:italic>
                     <ce:inf loc="post">m</ce:inf>) play an important role in mitochondrial apoptosis [<ce:cross-ref refid="bib16" id="crosref0035">16</ce:cross-ref>]. Emerging evidence indicates that a portion of STAT3 is located in the mitochondria and exerts an influence on the levels of ROS and Δ<ce:italic>ψ</ce:italic>
                     <ce:inf loc="post">m</ce:inf> to modulate mitochondrial apoptotic pathways [<ce:cross-refs refid="bib17 bib18 bib19 bib20 bib21 bib22 bib23 bib24" id="crosrefs0025">17–24</ce:cross-refs>].</ce:para>
                  <ce:para id="p0045" view="all">STAT3 activation is regulated by phosphorylation on tyrosine 705 (Tyr705) through receptor tyrosine kinases, which leads to its homodimerization, translocation into nucleus, DNA-binding and downstream transcriptional activities [<ce:cross-ref refid="bib17" id="crosref0040">17</ce:cross-ref>]. Whereas, except for Tyr705 phosphorylation, phosphorylation at serine 727 (Ser727) residue is also associated with the transcription, mitochondrial import and other biological functions of STAT3 protein [<ce:cross-ref refid="bib20" id="crosref0045">20</ce:cross-ref>,<ce:cross-ref refid="bib21" id="crosref0050">21</ce:cross-ref>,<ce:cross-refs refid="bib25 bib26 bib27" id="crosrefs0030">25–27</ce:cross-refs>]. In consequence, we speculated that simultaneous suppression of phosphorylation at Tyr705 and Ser727 residues might suppress STAT3 activation to a greater extent and thereby treat cancer.</ce:para>
                  <ce:para id="p0050" view="all">The benzo [<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide (BTP) moiety has the potential to inhibit Tyr705 phosphorylation of STAT3 as well as prominently suppress proliferation and enhance apoptosis of tumor cell by means of promoting ROS production. This makes BTP moiety an important pharmacophore of multiple STAT3 inhibitors, such as Stattic, HJC0123 and HJC0146 [<ce:cross-refs refid="bib28 bib29 bib30 bib31 bib32 bib33 bib34" id="crosrefs0035">28–34</ce:cross-refs>].</ce:para>
                  <ce:para id="p0055" view="all">Fluorescent probes targeting on subcellular organelles could function as real-time monitors of the therapeutic outcomes [<ce:cross-refs refid="bib35 bib36 bib37" id="crosrefs0040">35–37</ce:cross-refs>]. Coumarins were selected as fluorescent probes owing to their good physical properties, such as good water-solubility, photostability, small size and nontoxicity [<ce:cross-ref refid="bib38" id="crosref0055">38</ce:cross-ref>,<ce:cross-ref refid="bib39" id="crosref0060">39</ce:cross-ref>]. Fluorescent <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin with delocalized lipophilic cation can permeate the living cell membranes and accumulate preferentially in the mitochondria of cancer cells to be fluorescent mitochondria-targeted theranostic probe [<ce:cross-refs refid="bib40 bib41 bib42" id="crosrefs0045">40–42</ce:cross-refs>]. In 2015, Xu Zhang et al. reported that conjugating <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin fluorophore with antimalarial drug artemisinin could enhance anticancer activity, owing to the mitochondrial accumulation of artemisinin by the probe [<ce:cross-ref refid="bib42" id="crosref0065">42</ce:cross-ref>]. Similarly, Hong Yao et al. reported the possible anticancer mechanism of 23-hydroxybetulinic acid derivatives by combining fluorescent <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin with 23-hydroxybetulinic acid derivatives in 2018 [<ce:cross-ref refid="bib43" id="crosref0070">43</ce:cross-ref>].</ce:para>
                  <ce:para id="p0060" view="all">Herein, a series of coumarin-benzo [<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide hybrids were designed, synthesized and biologically evaluated as STAT3 mitochondria-targeting inhibitors (<ce:cross-ref refid="fig1" id="crosref0075">Fig. 1</ce:cross-ref>
                     <ce:float-anchor refid="fig1"/></ce:float-anchor>), triggering dual suppression of STAT3 phosphorylation on Tyr705 and Ser727. To the best of our knowledge, no fluorescent dual STAT3 phosphorylation inhibitors have been reported [<ce:cross-ref refid="bib29" id="crosref0080">29</ce:cross-ref>,<ce:cross-ref refid="bib30" id="crosref0085">30</ce:cross-ref>,<ce:cross-ref refid="bib34" id="crosref0090">34</ce:cross-ref>,<ce:cross-refs refid="bib44 bib45 bib46 bib47 bib48 bib49 bib50 bib51" id="crosrefs0050">44–51</ce:cross-refs>]. These hybrids were discovered to accumulate in mitochondria, cause Δ<ce:italic>ψ</ce:italic>
                     <ce:inf loc="post">m</ce:inf> depolarization, increase intracellular ROS and further induce apoptosis and necrosis. These new inhibitors might be promising candidates for cancer therapy.</ce:para>
               </ce:section>
               <ce:section id="sec2" role="results" view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title id="sectitle0040">Results and discussion</ce:section-title>
                  <ce:section id="sec2.1" view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title id="sectitle0045">Chemistry</ce:section-title>
                     <ce:para id="p0065" view="all">
                        <ce:cross-ref refid="sch1" id="crosref0095">Schemes 1</ce:cross-ref>
                        <ce:float-anchor refid="sch1"/></ce:float-anchor> outlined the synthetic routes for compounds <ce:bold>7a</ce:bold>-<ce:bold>7o</ce:bold>. The methyl benzo [<ce:italic>b</ce:italic>]thiophene-2-carboxylates <ce:bold>2a</ce:bold>-<ce:bold>2n</ce:bold> were prepared from the commercially available starting materials <ce:bold>1a</ce:bold>-<ce:bold>1n</ce:bold> and methyl thioglycolate, and were conveniently hydrolyzed to provide the corresponding acids <ce:bold>3a</ce:bold>-<ce:bold>3n</ce:bold> as described previously [<ce:cross-ref refid="bib31" id="crosref0100">31</ce:cross-ref>,<ce:cross-ref refid="bib34" id="crosref0105">34</ce:cross-ref>]. Using 2-(7-Azabenzotriazol-1-yl)-<ce:italic>N</ce:italic>,<ce:italic>N</ce:italic>,<ce:italic>N</ce:italic>ʹ,<ce:italic>N</ce:italic>ʹ-tetra-methyluronium hexafluorophosphate (HATU) as a coupling reagent, compounds <ce:bold>3a</ce:bold>-<ce:bold>3o</ce:bold> were reacted with tert-butyl-1-piperazinecarboxylate to afford intermediates <ce:bold>4a</ce:bold>-<ce:bold>4o</ce:bold>, which were then oxidized by 3-chloroperoxybenzoic acid to produce 2-carbonylbenzo [<ce:italic>b</ce:italic>]thiophene 1, 1-dioxides <ce:bold>5a</ce:bold>-<ce:bold>5o</ce:bold> [<ce:cross-ref refid="bib31" id="crosref0110">31</ce:cross-ref>,<ce:cross-ref refid="bib34" id="crosref0115">34</ce:cross-ref>]. After deprotecting <ce:italic>N</ce:italic>-Boc protection of <ce:bold>5a</ce:bold>-<ce:bold>5o</ce:bold> with trifluoroacetic acid (TFA), the desired compounds <ce:bold>7a</ce:bold>-<ce:bold>7o</ce:bold> were prepared by coupling with 7-(Diethylamino)coumarin-3-carboxylic acid <ce:bold>6</ce:bold> in the presence of HATU. All hybrids were confirmed by <ce:sup loc="pre">1</ce:sup>H NMR, <ce:sup loc="pre">13</ce:sup>C NMR, IR, and HRMS (ESI) spectrum.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.2" view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title id="sectitle0050">In vitro cell growth inhibition activity</ce:section-title>
                     <ce:para id="p0070" view="all">To evaluate <ce:italic>in vitro</ce:italic> tumor cell growth inhibitory activity of all compounds and explore the structure-activity relationships, four STAT3 over-activated human cancer cell lines, including human breast carcinoma MDA-MB-231 cells and MCF-7 cells, human colonic carcinoma HCT-116 cells and human hepatocellular carcinoma HepG2 cells, were treated with designed compounds and the positive control <ce:bold>Stattic</ce:bold>, by MTT assay. As shown in <ce:cross-ref refid="tbl1" id="crosref0120">Table 1</ce:cross-ref>
                        <ce:float-anchor refid="tbl1"/></ce:float-anchor>, all designed compounds displayed potent anti-proliferative activity against four cancer cells. In contrast to BTP (IC<ce:inf loc="post">50</ce:inf> = 27.65 μM for MDA-MB-231 cells), the intercalation of fluorescent coumarin (<ce:bold>7o</ce:bold>) significantly enhanced cell growth inhibitory activity. In general, compounds with electron-withdrawing substitutes such as nitro substituent (<ce:bold>7j</ce:bold> and <ce:bold>7l</ce:bold>) or halogen substituents (<ce:bold>7c</ce:bold>, <ce:bold>7e</ce:bold>, <ce:bold>7g</ce:bold>, <ce:bold>7h</ce:bold> and <ce:bold>7i</ce:bold>) were less active than those with electron-donating substitutes such as methoxy substituent (<ce:bold>7<ce:italic>m</ce:italic>
                        </ce:bold> and <ce:bold>7n</ce:bold>) except compound <ce:bold>7a,</ce:bold> which bears a bromo substituent at 4 position of the BTP ring. Compared with compound <ce:bold>7o,</ce:bold> compounds with the methoxy substituent (such as <ce:bold>7<ce:italic>m</ce:italic>
                        </ce:bold> and <ce:bold>7n</ce:bold>) exhibited enhanced anticancer activity, while that with nitro substituent (<ce:bold>7j</ce:bold>, <ce:bold>7k</ce:bold> and <ce:bold>7l</ce:bold>) led to a decreased activity. The compound with a 4-bromo substitute on the BTP ring (<ce:bold>7a</ce:bold>) had a slightly stronger activity than compounds with a bromine substitute at 5, 6 or 7 position on the BTP ring (<ce:bold>7b</ce:bold>, <ce:bold>7c</ce:bold> and <ce:bold>7d</ce:bold>). The most potent compound <ce:bold>7a</ce:bold> inhibited the growth of MDA-MB-231, HCT-116, HepG2, and MCF-7 cells with IC<ce:inf loc="post">50</ce:inf> values of 1.43, 1.89, 2.88, and 3.33 μM respectively, which showed 4.6- to 19-fold improvement in activity than compound <ce:bold>8</ce:bold> (BTP). The anti-proliferative effects of compound <ce:bold>7a</ce:bold> on normal cells were investigated by MTT assays subsequently. As shown in <ce:cross-ref refid="tbl2" id="crosref0125">Table 2</ce:cross-ref>
                        <ce:float-anchor refid="tbl2"/></ce:float-anchor>, <ce:bold>Stattic</ce:bold> has growth inhibition activity in both tumor and normal cells, while compound <ce:bold>7a</ce:bold> exhibited selective inhibitory activity against cancer cells (IC<ce:inf loc="post">50</ce:inf> = 14.62 μM for MCF-10 A cells and IC<ce:inf loc="post">50</ce:inf> = 35.60 μM for L02 cells) and selectivity index was 10.2 and 12.4 respectively, indicating <ce:italic>in vitro</ce:italic> comparatively better safety of compound <ce:bold>7a</ce:bold> than <ce:bold>Stattic</ce:bold>.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.3" view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title id="sectitle0055">Compound <ce:bold>7a</ce:bold> reduced colony formation <ce:italic>in vitro</ce:italic>
                     </ce:section-title>
                     <ce:para id="p0075" view="all">STAT3 has been demonstrated to drive colony formation, which was mediated by its phosphorylation of Tyr705 and Ser727 [<ce:cross-ref refid="bib20" id="crosref0130">20</ce:cross-ref>]. Consequently, we performed colony survival assay to further explore the anti-proliferative activity of compound <ce:bold>7a</ce:bold>. As shown in <ce:cross-ref refid="fig2" id="crosref0135">Fig. 2</ce:cross-ref>
                        <ce:float-anchor refid="fig2"/></ce:float-anchor>, treatment with 1 μM of compound <ce:bold>7a</ce:bold> markedly inhibited the proliferation of MDA-MB-231 cells and there was almost a cessation of colony formation at 2 μM compound <ce:bold>7a</ce:bold>. Therefore, similar to data from the MTT assays, compound <ce:bold>7a</ce:bold> could suppress the proliferation of STAT3 dependent MDA-MB-231 cells.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.4" view="all">
                     <ce:label>2.4</ce:label>
                     <ce:section-title id="sectitle0060">Compound <ce:bold>7a</ce:bold> induced apoptosis in cancer cells</ce:section-title>
                     <ce:para id="p0080" view="all">To explore whether the anti-proliferative potency of compound <ce:bold>7a</ce:bold> was consistent with the induction of apoptosis, Annexin V-FITC/PI staining assay was performed by flow cytometry. The results showed that compound <ce:bold>7a</ce:bold> could induce the apoptosis of MDA-MB-231 cells dose-dependently and the apoptosis rates (early and late apoptosis) at 0, 1, 2, 4 μM were 4.2%, 6.6%, 9.2% and 20.4% (<ce:cross-ref refid="fig3" id="crosref0140">Fig. 3</ce:cross-ref>
                        <ce:float-anchor refid="fig3"/></ce:float-anchor>A). To confirm that apoptotic effects in MDA-MB-231 cells by compound <ce:bold>7a</ce:bold> were exerted <ce:italic>via</ce:italic> the mitochondrial pathway, we evaluated the protein levels of Cleaved Caspases-9 and Cleaved Caspases-3 and Cleaved PARP in MDA-MB-231 cells after treatment with compound <ce:bold>7a</ce:bold> (1–4 μM) or <ce:bold>Stattic</ce:bold> (4 μM) for 24 h by western blotting. As shown in <ce:cross-ref refid="fig3" id="crosref0145">Fig. 3</ce:cross-ref>B, compound <ce:bold>7a</ce:bold> could induce the cleavage of Caspase-9, Caspase-3 and PARP, which were similar to the positive STAT3 inhibitor <ce:bold>Stattic</ce:bold> (<ce:cross-ref refid="appsec1" id="crosref0150">Fig. S1A in the Supporting Information</ce:cross-ref>). Thus, we supposed that cytotoxicity of compound <ce:bold>7a</ce:bold> in cancer cells is mainly through the mitochondrial Caspase-dependent apoptotic pathway, which was potentially regulated by the deactivation of STAT3 protein.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.5" view="all">
                     <ce:label>
                        <ce:italic>2.5</ce:italic>
                     </ce:label>
                     <ce:section-title id="sectitle0065">
                        <ce:italic>Compound</ce:italic> 
                        <ce:bold>
                           <ce:italic>7a</ce:italic>
                        </ce:bold> 
                        <ce:italic>accumulated in mitochondria</ce:italic>
                     </ce:section-title>
                     <ce:para id="p0085" view="all">It was reported that compounds conjugated with the <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin fluorophore might accumulate in mitochondria [<ce:cross-ref refid="bib41" id="crosref0155">41</ce:cross-ref>,<ce:cross-ref refid="bib42" id="crosref0160">42</ce:cross-ref>]. To determine the role of compound <ce:bold>7a</ce:bold> as a mitochondrial probe, we investigated the subcellular localization of compound <ce:bold>7a</ce:bold>. MitoTracker (mitochondria-specific dye; <ce:cross-ref refid="fig4" id="crosref0165">Fig. 4</ce:cross-ref>
                        <ce:float-anchor refid="fig4"/></ce:float-anchor>b), and LysoTracker (Lysosome-specific dye; <ce:cross-ref refid="appsec1" id="crosref0170">Fig. S2b</ce:cross-ref> in the Supporting Information) were employed for colocalization experiments in human breast carcinoma MDA-MB-231 cells and MCF-7 cells. The preferential concentration of compound <ce:bold>7a</ce:bold> for study was 2 μM and 5 μM respectively. MDA-MB-231 cells and MCF-7 cells were stained by compound <ce:bold>7a</ce:bold> after 60 min of incubation and strong blue fluorescence was detected as shown in <ce:cross-ref refid="fig4" id="crosref0175">Fig. 4</ce:cross-ref>a and <ce:cross-ref refid="appsec1" id="crosref0180">Fig. S2a (Supporting Information)</ce:cross-ref>. The colocalization study revealed that the fluorescence of compound <ce:bold>7a</ce:bold> overlapped exactly with that of MitoTracker Red, with an extensive magenta color in the merged image (<ce:cross-ref refid="fig4" id="crosref0185">Fig. 4</ce:cross-ref>c) but that of Lysosome, with only partial colocalization <ce:cross-ref refid="appsec1" id="crosref0190">(Fig. S2c in the Supporting Information)</ce:cross-ref>. The results confirmed that compound <ce:bold>7a</ce:bold> was accumulated to mitochondria by the aid of the fluorescent <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin moiety.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.6" view="all">
                     <ce:label>2.6</ce:label>
                     <ce:section-title id="sectitle0070">Compound <ce:bold>7a</ce:bold> affected the mitochondrial membrane potential (Δψ<ce:inf loc="post">m</ce:inf>)</ce:section-title>
                     <ce:para id="p0090" view="all">The level of mitochondrial membrane potential <ce:italic>(Δψ</ce:italic>
                        <ce:inf loc="post">
                           <ce:italic>m</ce:italic>
                        </ce:inf>
                        <ce:italic>)</ce:italic> was more elevated in cancer cells than that in normal cells, which could be exploited therapeutically to selectively target compounds to the mitochondria of cancer cells [<ce:cross-ref refid="bib52" id="crosref0195">52</ce:cross-ref>]. And changes in <ce:italic>Δψ</ce:italic>
                        <ce:inf loc="post">
                           <ce:italic>m</ce:italic>
                        </ce:inf> have been shown to play an important role in mitochondrial apoptosis [<ce:cross-ref refid="bib16" id="crosref0200">16</ce:cross-ref>]. Taking into consideration that the hybrids were designed to target mitochondria and to induce mitochondrial apoptosis, we continued to investigate the effect of compound <ce:bold>7a</ce:bold> on Δ<ce:italic>ψ</ce:italic>
                        <ce:inf loc="post">m</ce:inf> of MDA-MB-231 cells using JC-1 assay kit. Changes in Δ<ce:italic>ψ</ce:italic>
                        <ce:inf loc="post">m</ce:inf> were reflected by the increase of J-monomers (green fluorescence) and concurrent decrease of J-aggregates (red fluorescence). As shown in <ce:cross-ref refid="fig5" id="crosref0205">Fig. 5</ce:cross-ref>
                        <ce:float-anchor refid="fig5"/></ce:float-anchor>, treatment with compound <ce:bold>7a</ce:bold> led to increased intensity of green fluorescence in a dose-dependent manner. These data suggested that compound <ce:bold>7a</ce:bold> induced the depolarization of mitochondrial membrane potential and subsequently induced mitochondrial damage and apoptosis of cancer cells.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.7" view="all">
                     <ce:label>2.7</ce:label>
                     <ce:section-title id="sectitle0075">Compound <ce:bold>7a</ce:bold> induced the ROS generation in cancer cells</ce:section-title>
                     <ce:para id="p0095" view="all">Mitochondria are the main organelle that produce ROS and previous studies have suggested that constitutively activated STAT3 phosphorylated on Ser727 in the mitochondria could decrease the amount of ROS, causing decreased apoptosis and enhanced tumor cell growth [<ce:cross-ref refid="bib5" id="crosref0210">5</ce:cross-ref>,<ce:cross-ref refid="bib21" id="crosref0215">21</ce:cross-ref>,<ce:cross-ref refid="bib53" id="crosref0220">53</ce:cross-ref>]. We next evaluated ROS production after treating with compound <ce:bold>7a</ce:bold> at different concentrations in MDA-MB-231 cells for 24 h by flow cytometry analysis. As shown in <ce:cross-ref refid="fig6" id="crosref0225">Fig. 6</ce:cross-ref>
                        <ce:float-anchor refid="fig6"/></ce:float-anchor>, compound <ce:bold>7a</ce:bold> induced ROS accumulation in a dose-dependent manner, indicating that compound <ce:bold>7a</ce:bold> could increase ROS production which is also responsible for mitochondrial apoptosis and necrosis of cancer cell.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.8" view="all">
                     <ce:label>2.8</ce:label>
                     <ce:section-title id="sectitle0080">Compound <ce:bold>7a</ce:bold> inhibited STAT3 tyrosine phosphorylation and serine phosphorylation</ce:section-title>
                     <ce:para id="p0100" view="all">BTP moiety could suppress the phosphorylation of STAT3 on Tyr705 but have minimal impact on STAT3 phosphorylation on Ser727 [<ce:cross-ref refid="bib33" id="crosref0230">33</ce:cross-ref>]. To examine whether the aforementioned improved antitumor activities <ce:italic>in vitro</ce:italic> were derived from addition of the mitochondria-targeting <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin fluorophore to inhibit STAT3 phosphorylation at Ser727 residue, the p-STAT3 (Tyr705 and Ser727) protein levels were investigated on MDA-MB-231 cells by western blotting assays. MDA-MB-231 cells were treated with compound <ce:bold>7a</ce:bold> (1–4 μM) or <ce:bold>Stattic</ce:bold> (4 μM) for 24 h and the phosphorylated and total STAT3 protein levels were examined. As shown in <ce:cross-ref refid="fig7" id="crosref0235">Fig. 7</ce:cross-ref>
                        <ce:float-anchor refid="fig7"/></ce:float-anchor>A, compound <ce:bold>7a</ce:bold> markedly inhibited STAT3 phosphorylation at Tyr705 residue as well as STAT3 phosphorylation at Ser727 residue in a dose-dependent manner but total STAT3 proteins remain unaffected, while <ce:bold>Stattic</ce:bold> only inhibited STAT3 phosphorylation at Tyr705 residue <ce:cross-ref refid="appsec1" id="crosref0240">(Fig. S1B in the Supporting Information)</ce:cross-ref>. These results indicated that compound <ce:bold>7a</ce:bold> was a dual STAT3 inhibitor that including BTP moiety to suppress the phosphorylation of STAT3 on Tyr705 and the mitochondria-targeting <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin fluorophore to make compound accumulate to mitochondria, inhibit STAT3 phosphorylation on Ser727 and thereby induce mitochondrial damage and apoptosis.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.9" view="all">
                     <ce:label>2.9</ce:label>
                     <ce:section-title id="sectitle0085">Compound <ce:bold>7a</ce:bold> inhibited STAT3 DNA-binding activity</ce:section-title>
                     <ce:para id="p0105" view="all">Maximal transcriptional activity of STAT3 requires both phosphorylation on tyrosine 705 and serine 727 [<ce:cross-ref refid="bib27" id="crosref0245">27</ce:cross-ref>]. In consideration of the inhibitory effect of compound <ce:bold>7a</ce:bold> on p-STAT3 in tumor cells, we performed electrophoretic mobility shift assay (EMSA) to evaluate the inhibition of STAT3:STAT3 DNA-binding activity. After treated with compound <ce:bold>7a</ce:bold> (1–4 μM) or <ce:bold>Stattic</ce:bold> (4 μM) for 24 h, nuclear extracts of MDA-MB-231 cells were incubated with hSIE probe and EMSA assay was performed. The capability of STAT3:STAT3 binding DNA was decreased by compound <ce:bold>7a</ce:bold> at a start concentration at 1 μM and an obvious diminish at 4 μM as compared with <ce:bold>Stattic</ce:bold> at 4 μM (<ce:cross-ref refid="fig7" id="crosref0250">Fig. 7</ce:cross-ref>B), which indicated that compound <ce:bold>7a</ce:bold> effectively suppressed STAT3 activation.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.10" view="all">
                     <ce:label>2.10</ce:label>
                     <ce:section-title id="sectitle0090">Compound <ce:bold>7a</ce:bold> did not affect STAT1 phosphorylation and typical upstream or other kinases of STAT3</ce:section-title>
                     <ce:para id="p0110" view="all">STAT1, another member of the STATs family, can inhibit cancer cell proliferation and induce apoptosis. As shown in <ce:cross-ref refid="fig7" id="crosref0255">Fig. 7</ce:cross-ref>A and <ce:cross-ref refid="appsec1" id="crosref0260">Fig. S1B</ce:cross-ref> by western blotting assays, compound <ce:bold>7a</ce:bold> and <ce:bold>Stattic</ce:bold> had little effect on STAT1 phosphorylation. Upstream kinases (such as JAK2, Src) can phosphorylate tyrosine residues of STAT3 and the Erk family of mitogen-activated protein kinases can stimulates STAT3 phosphorylation on Ser727 [<ce:cross-ref refid="bib54" id="crosref0265">54</ce:cross-ref>]. We evaluated the effects of compound <ce:bold>7a</ce:bold> on the phosphorylation of JAK2, Src and Erk1/2 b y western blotting assays to investigate the selectivity of compound <ce:bold>7a</ce:bold> targeting the phosphorylation of STAT3. As shown in <ce:cross-ref refid="fig7" id="crosref0270">Fig. 7</ce:cross-ref>C, compound <ce:bold>7a</ce:bold> had no effect on <ce:italic>p</ce:italic>-JAK2, <ce:italic>p</ce:italic>-Src and <ce:italic>p</ce:italic>-Erk1/2 as same as <ce:bold>Stattic</ce:bold> (<ce:cross-ref refid="appsec1" id="crosref0275">Fig. S1C</ce:cross-ref>). These results showed that the phosphorylation inhibition of STAT3 by compound <ce:bold>7a</ce:bold> was selective and independent of these related kinases.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.11" view="all">
                     <ce:label>2.11</ce:label>
                     <ce:section-title id="sectitle0095">Molecular docking study</ce:section-title>
                     <ce:para id="p0115" view="all">Given that compound <ce:bold>7a</ce:bold> could inhibit the phosphorylation of STAT3 without influencing other related kinases, to determine whether compound <ce:bold>7a</ce:bold> is a direct STAT3 SH2 domain inhibitor, we performed docking assay for predicting potential binding modes of compound <ce:bold>7a</ce:bold> with STAT3 SH2 domain (PDB: <ce:inter-ref xlink:href="pdb:1BG1" id="intref0010" xlink:type="simple">1BG1</ce:inter-ref>). As shown in <ce:cross-ref refid="fig8" id="crosref0280">Fig. 8</ce:cross-ref>
                        <ce:float-anchor refid="fig8"/></ce:float-anchor>, the benzo [<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide and coumarin fragments of compound <ce:bold>7a</ce:bold> perfectly overlapped with the native hot spot pTyr705 site and side pocket of STAT3 SH2 domain <ce:italic>via</ce:italic> forming four hydrogen bonding interactions with the Arg 609 residues (distance = 1.593 Å and 2.144 Å), Lys 591 residues (distance = 2.146 Å) and Arg 595 residues (distance = 2.185 Å). The predicted binding energy was −7.8 kcal/mol. Moreover, suitable length and angle of piperazine fragment contributed to interact with the two binding pocket of STAT3. Therefore, compound <ce:bold>7a</ce:bold> was speculated to be a direct STAT3 SH2 domain inhibitor.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.12" view="all">
                     <ce:label>2.12</ce:label>
                     <ce:section-title id="sectitle0100">Compound <ce:bold>7a</ce:bold> affected the expression of STAT3 targeted genes</ce:section-title>
                     <ce:para id="p0120" view="all">Several proteins such as anti-apoptotic Bcl-2 protein and Cyclin D1 involved in cell cycle progression have been found to associate directly with STAT3. Hence, looking for more insights in the mechanism of compound <ce:bold>7a</ce:bold> on the STAT3 pathway, we estimated the effects of compound <ce:bold>7a</ce:bold> on the expression levels of Bcl-2 and Cyclin D1 using western blotting and compared with <ce:bold>Stattic</ce:bold> (<ce:cross-ref refid="appsec1" id="crosref0285">Fig. S1A</ce:cross-ref>). After treatment with compound <ce:bold>7a</ce:bold> for 24 h, Bcl-2 and Cyclin D1 protein levels were decreased in a concentration-dependent manner (<ce:cross-ref refid="fig7" id="crosref0290">Fig. 7</ce:cross-ref>D). These results demonstrated that compound <ce:bold>7a</ce:bold> suppressed the protein levels of p-STAT3 (Y705) and p-STAT3 (S727), inhibited STAT3:STAT3 DNA-binding activity and consequently down-regulated the expression of STAT3 target genes.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.13" view="all">
                     <ce:label>2.13</ce:label>
                     <ce:section-title id="sectitle0105">Compound <ce:bold>7a</ce:bold> exhibited antitumor activity <ce:italic>in vivo</ce:italic>
                     </ce:section-title>
                     <ce:para id="p0125" view="all">To evaluate <ce:italic>in vivo</ce:italic> antitumor effect of compound <ce:bold>7a</ce:bold>, we established a mouse-xenograft model bearing inoculation of STAT3 over-expressed and over-activated mouse breast cancer 4T1 cells as reported previously [<ce:cross-ref refid="bib34" id="crosref0295">34</ce:cross-ref>,<ce:cross-ref refid="bib50" id="crosref0300">50</ce:cross-ref>,<ce:cross-ref refid="bib55" id="crosref0305">55</ce:cross-ref>]. The mice were randomly assigned and treated with doses (10 mg/kg, 20 mg/kg) of compound <ce:bold>7a</ce:bold> or the vehicle daily by intraperitoneal injection for 14 consecutive days. As shown in <ce:cross-ref refid="fig9" id="crosref0310">Fig. 9</ce:cross-ref>
                        <ce:float-anchor refid="fig9"/></ce:float-anchor>, compound <ce:bold>7a</ce:bold> significantly inhibited tumor volume (52.29% decrease at 10 mg/kg, 61.20% decrease at 20 mg/kg) and weight (39.67% decrease at 10 mg/kg, 56.86% decrease at 20 mg/kg). Western blotting assays showed that compound <ce:bold>7a</ce:bold> inhibited the p-STAT3 (Y705) level in tumor tissue. All these results indicated that compound <ce:bold>7a</ce:bold> possessed potent antitumor activity against implanted 4T1 breast tumors growth.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="sec3" role="conclusion" view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title id="sectitle0110">Conclusions</ce:section-title>
                  <ce:para id="p0130" view="all">In the present study, we have designed and synthesized a series of mitochondria-targeting STAT3 inhibitors by conjugating BTP moiety with <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin fluorophore, and evaluated their anticancer activities <ce:italic>in vitro</ce:italic> and <ce:italic>in vivo</ce:italic>. In contrast to the compound BTP, new STAT3 inhibitors revealed remarkable higher potency, represented by the most potent compound <ce:bold>7a</ce:bold>. Compound <ce:bold>7a</ce:bold> showed more anticancer activity and comparatively better safety than the positive STAT3 inhibitor <ce:bold>Stattic</ce:bold>. Subcellular localization studies visualized that compound <ce:bold>7a</ce:bold> was accumulated to mitochondria by the aid of the fluorescent <ce:italic>N</ce:italic>, <ce:italic>N</ce:italic>-diethyl-7-aminocoumarin moiety. The promoted ROS and reduced Δ<ce:italic>ψ</ce:italic>
                     <ce:inf loc="post">m</ce:inf> by compound <ce:bold>7a</ce:bold> induced mitochondrial apoptosis pathway and the cessation of tumor cells colony formation. Further biological evaluation showed that compound <ce:bold>7a</ce:bold> inhibited Tyr705 and Ser727 STAT3 phosphorylation, STAT3:STAT3 DNA-binding activity and regulated the expression of the STAT3 downstream genes Bcl-2 and Cyclin D1, with little effect on the phosphorylation of STAT1 and related kinases (JAK2, Src and Erk1/2). Docking studies revealed that compound <ce:bold>7a</ce:bold> might be a STAT3-SH2 domain inhibitor. Furthermore, compound <ce:bold>7a</ce:bold> significantly inhibited breast cancer 4T1 implanted tumor growth <ce:italic>in vivo</ce:italic>. In summary, all evidences highlight that compound <ce:bold>7a</ce:bold> is a promising mitochondria-targeting STAT3 inhibitor for cancer therapy.</ce:para>
               </ce:section>
               <ce:section id="sec4" role="materials-methods" view="all">
                  <ce:label>4</ce:label>
                  <ce:section-title id="sectitle0115">Materials and methods</ce:section-title>
                  <ce:section id="sec4.1" view="all">
                     <ce:label>4.1</ce:label>
                     <ce:section-title id="sectitle0120">Chemistry</ce:section-title>
                     <ce:para id="p0135" view="all">All chemicals were obtained from commercial suppliers and used without further purification. Reaction progress was monitored using analytical thin layer chromatography (TLC) on precoated silica gel GF254 plates (Qingdao Haiyang Chemical Plant, Qingdao, China) and the spots were detected under UV light (254 nm). Melting point was measured on an XT-4 point instrument and uncorrected. IR (KBr-disc) spectra were recorded by Bruker Tensor 27 spectrometer. <ce:sup loc="pre">1</ce:sup>H NMR and <ce:sup loc="pre">13</ce:sup>C NMR spectra were measured on a Bruker ACF-500 spectrometer at 25 °C and referenced to TMS. Chemical shifts are reported in ppm (<ce:italic>δ</ce:italic>) using the residual solvent line as internal standard. Splitting patterns were designed as s, singlet; br. s, broad single; d, doublet; t, triplet; m, multiplet. The purity of all compounds used for biological evaluation was confirmed to be higher than 95% through analytical HPLC performed with Agilent 1100 HPLC System. Mass spectra were obtained on a MS Agilent 1100 Series LC/MSD Trap mass spectrometer (ESI-MS) and a Mariner ESI-TOF spectrometer (HRESI-MS), respectively.</ce:para>
                     <ce:section id="sec4.1.1" view="all">
                        <ce:label>4.1.1</ce:label>
                        <ce:section-title id="sectitle0125">General procedures for the preparation of <ce:bold>2a</ce:bold>-<ce:bold>2n</ce:bold>
                        </ce:section-title>
                        <ce:para id="p0140" view="all">To a stirred solution of compound <ce:bold>1a</ce:bold>-<ce:bold>1n</ce:bold> (9.90 mmol) in DMF (20 mL) were added methyl thioglycolate (10.9 mmol) and potassium carbonate (39.6 mmol). The resulting mixture was stirred at 60 °C for 15 h. The DMF was removed under reduced pressure, water (50 mL) was added and the mixture was extracted with ethyl acetate (2 × 40 mL). The combined organic layers were dried with sodium sulfate, filtered, and the solvents were removed under reduced pressure to afford the title compound <ce:bold>2a</ce:bold>-<ce:bold>2n</ce:bold> [<ce:cross-ref refid="bib31" id="crosref0315">31</ce:cross-ref>,<ce:cross-ref refid="bib34" id="crosref0320">34</ce:cross-ref>]<ce:bold>
                              <ce:italic>.</ce:italic>
                           </ce:bold>
                        </ce:para>
                        <ce:section id="sec4.1.1.1" view="all">
                           <ce:label>4.1.1.1</ce:label>
                           <ce:section-title id="sectitle0130">Methyl 4-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2a</ce:bold>)</ce:section-title>
                           <ce:para id="p0145" view="all">Yield 89%, white solid; m. p. 77–78 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.12 (d, <ce:italic>J</ce:italic> = 8.2 Hz, 1H), 8.01 (d, <ce:italic>J</ce:italic> = 0.6 Hz, 1H), 7.73 (d, <ce:italic>J</ce:italic> = 7.7 Hz, 1H), 7.46 (t, <ce:italic>J</ce:italic> = 7.9 Hz, 1H), 3.91 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.2" view="all">
                           <ce:label>4.1.1.2</ce:label>
                           <ce:section-title id="sectitle0135">Methyl 5-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2b</ce:bold>)</ce:section-title>
                           <ce:para id="p0150" view="all">Yield 92%, white solid; m. p. 82–84 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.28 (d, <ce:italic>J</ce:italic> = 1.9 Hz, 1H), 8.17 (s, 1H), 8.06 (d, <ce:italic>J</ce:italic> = 8.7 Hz, 1H), 7.67 (dd, <ce:italic>J</ce:italic> = 8.7, 2.0 Hz, 1H), 3.89 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.3" view="all">
                           <ce:label>4.1.1.3</ce:label>
                           <ce:section-title id="sectitle0140">Methyl 6-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2c</ce:bold>)</ce:section-title>
                           <ce:para id="p0155" view="all">Yield 94%, white solid; m. p. 79–81 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.40 (s, 1H), 8.21 (s, 1H), 7.97 (d, <ce:italic>J = </ce:italic>8.6 Hz, 1H), 7.64 (dd, <ce:italic>J</ce:italic> = 8.6, 1.8 Hz, 1H), 3.89 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.4" view="all">
                           <ce:label>4.1.1.4</ce:label>
                           <ce:section-title id="sectitle0145">Methyl 7-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2d</ce:bold>)</ce:section-title>
                           <ce:para id="p0160" view="all">Yield 94%, white solid; m. p. 87–88 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 8.17 (s, 1H), 7.86 (d, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 7.63 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 7.31 (dd, <ce:italic>J</ce:italic> = 16.2, 8.4 Hz, 1H), 3.99 (s, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.5" view="all">
                           <ce:label>4.1.1.5</ce:label>
                           <ce:section-title id="sectitle0150">Methyl 4-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2e</ce:bold>)</ce:section-title>
                           <ce:para id="p0165" view="all">Yield 89%, white solid; m. p. 80–82 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 8.78 (s, 1H), 8.32 (s, 1H), 7.89 (d, <ce:italic>J</ce:italic> = 7.4 Hz, 1H), 7.44 (dd, <ce:italic>J</ce:italic> = 8.9, 6.9 Hz, 2H), 3.89 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.6" view="all">
                           <ce:label>4.1.1.6</ce:label>
                           <ce:section-title id="sectitle0155">Methyl 5-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2f</ce:bold>)</ce:section-title>
                           <ce:para id="p0170" view="all">Yield 91%, gray solid; m. p. 72–74 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.15 (s, 1H), 8.11 (s, 1H), 8.11 (d, <ce:italic>J</ce:italic> = 7.0 Hz, 1H), 7.55 (dd, <ce:italic>J</ce:italic> = 8.7, 2.2 Hz, 1H), 3.89 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.7" view="all">
                           <ce:label>4.1.1.7</ce:label>
                           <ce:section-title id="sectitle0160">Methyl 6-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2g</ce:bold>)</ce:section-title>
                           <ce:para id="p0175" view="all">Yield 90%, white solid; m. p. 67–69 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 8.02 (d, <ce:italic>J</ce:italic> = 6.4 Hz, 1H), 7.88–7.84 (m, 1H), 7.80 (d, <ce:italic>J</ce:italic> = 8.6 Hz, 1H), 7.39 (dd, <ce:italic>J</ce:italic> = 8.6, 1.8 Hz, 1H), 3.97 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.8" view="all">
                           <ce:label>4.1.1.8</ce:label>
                           <ce:section-title id="sectitle0165">Methyl 4-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2h</ce:bold>)</ce:section-title>
                           <ce:para id="p0180" view="all">Yield 85%, white solid; m. p. 75–77 °C; 1H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.11 (s, 1H), 7.93 (t, <ce:italic>J</ce:italic> = 14.4 Hz, 1H), 7.64–7.49 (m, 1H), 7.29 (dd, <ce:italic>J</ce:italic> = 10.1, 8.1 Hz, 1H), 3.90 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.9" view="all">
                           <ce:label>4.1.1.9</ce:label>
                           <ce:section-title id="sectitle0170">Methyl 6-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2i</ce:bold>)</ce:section-title>
                           <ce:para id="p0185" view="all">Yield 93%, orange solid; m. p. 89–90 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.22 (d, <ce:italic>J</ce:italic> = 7.2 Hz, 1H), 8.11–8.05 (m, 1H), 8.04–7.99 (m, 1H), 7.42–7.34 (m, 1H), 3.89 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.10" view="all">
                           <ce:label>4.1.1.10</ce:label>
                           <ce:section-title id="sectitle0175">Methyl 4-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2j</ce:bold>)</ce:section-title>
                           <ce:para id="p0190" view="all">Yield 70%, brown solid; m. p. 111–114 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.63 (d, <ce:italic>J</ce:italic> = 8.8 Hz, 1H), 8.12 (d, <ce:italic>J</ce:italic> = 28.1 Hz, 1H), 7.98–7.88 (m, 1H), 7.80 (t, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 3.95 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.11" view="all">
                           <ce:label>4.1.1.11</ce:label>
                           <ce:section-title id="sectitle0180">Methyl 5-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2k</ce:bold>)</ce:section-title>
                           <ce:para id="p0195" view="all">Yield 76%, pale yellow solid; m. p. 87–88 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.00 (s, 1H), 8.44 (s, 1H), 8.37 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 1H), 8.32 (d, <ce:italic>J</ce:italic> = 8.6 Hz, 1H), 3.92 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.12" view="all">
                           <ce:label>4.1.1.12</ce:label>
                           <ce:section-title id="sectitle0185">Methyl 6-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2l</ce:bold>)</ce:section-title>
                           <ce:para id="p0200" view="all">Yield 70%, brown solid; m. p. 67–68 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.38 (s, 1H), 8.28–8.25 (m, 1H), 7.76–7.71 (m, 1H), 7.26 (dd, <ce:italic>J</ce:italic> = 25.2, 10.0 Hz, 1H), 3.93 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.13" view="all">
                           <ce:label>4.1.1.13</ce:label>
                           <ce:section-title id="sectitle0190">Methyl 4-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2<ce:italic>m</ce:italic>
                              </ce:bold>)</ce:section-title>
                           <ce:para id="p0205" view="all">Yield 91%, white solid; m. p. 69–71 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.06 (s, 1H), 7.62–7.58 (m, 1H), 7.51–7.47 (m, 1H), 6.97 (d, <ce:italic>J</ce:italic> = 7.9 Hz, 1H), 3.94 (s, 3H), 3.87 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.1.14" view="all">
                           <ce:label>4.1.1.14</ce:label>
                           <ce:section-title id="sectitle0195">Methyl 6-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylate (<ce:bold>2n</ce:bold>)</ce:section-title>
                           <ce:para id="p0210" view="all">Yield 84%, white solid; m. p. 77–79 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.97 (s, 1H), 7.74 (d, <ce:italic>J</ce:italic> = 8.8 Hz, 1H), 7.28 (d, <ce:italic>J</ce:italic> = 1.8 Hz, 1H), 7.05–6.99 (m, 1H), 3.92 (s, 3H), 3.89 (s, 3H).</ce:para>
                        </ce:section>
                     </ce:section>
                     <ce:section id="sec4.1.2" view="all">
                        <ce:label>4.1.2</ce:label>
                        <ce:section-title id="sectitle0200">General procedures for the preparation of <ce:bold>3a</ce:bold>-<ce:bold>3n</ce:bold>
                        </ce:section-title>
                        <ce:para id="p0215" view="all">The solution of compound <ce:bold>2a-2n (</ce:bold>1.1 mmol) in water (10 mL) was stirred and then potassium hydroxide pellets (5.4 mmol) were added, which was refluxed for 3 h. The aqueous layer was then acidified to pH 1 with 1 M hydrochloric acid solution. The aqueous layer was extracted with dichloromethane (3 × 15 mL). The combined organic layers were dried with sodium sulfate, filtered, and the solvents were removed under reduced pressure to afford the title compound <ce:bold>3a</ce:bold>-<ce:bold>3n</ce:bold> [<ce:cross-ref refid="bib31" id="crosref0325">31</ce:cross-ref>,<ce:cross-ref refid="bib34" id="crosref0330">34</ce:cross-ref>].</ce:para>
                        <ce:section id="sec4.1.2.1" view="all">
                           <ce:label>4.1.2.1</ce:label>
                           <ce:section-title id="sectitle0205">4-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3a</ce:bold>)</ce:section-title>
                           <ce:para id="p0220" view="all">Yield 97%, white solid; m. p. 140–143 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 13.78 (s, 1H), 8.10 (d, <ce:italic>J</ce:italic> = 8.2 Hz, 1H), 7.96 (s, 1H), 7.71 (d, <ce:italic>J</ce:italic> = 7.7 Hz, 1H), 7.44 (dt, <ce:italic>J</ce:italic> = 13.1, 2.7 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.2" view="all">
                           <ce:label>4.1.2.2</ce:label>
                           <ce:section-title id="sectitle0210">5-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3b</ce:bold>)</ce:section-title>
                           <ce:para id="p0225" view="all">Yield 95%, white solid; m. p. 133–135 °C; <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.18 (d, <ce:italic>J</ce:italic> = 1.8 Hz, 1H), 7.96 (d, <ce:italic>J</ce:italic> = 8.6 Hz, 1H), 7.85 (s, 1H), 7.57 (dd, <ce:italic>J</ce:italic> = 8.6, 1.9 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.3" view="all">
                           <ce:label>4.1.2.3</ce:label>
                           <ce:section-title id="sectitle0215">6-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3c</ce:bold>)</ce:section-title>
                           <ce:para id="p0230" view="all">Yield 96%, white solid; m. p. 122–124 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.27 (s, 1H), 7.91–7.85 (m, 1H), 7.84 (s, 1H), 7.55 (dd, <ce:italic>J</ce:italic> = 8.5, 1.7 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.4" view="all">
                           <ce:label>4.1.2.4</ce:label>
                           <ce:section-title id="sectitle0220">7-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3d</ce:bold>)</ce:section-title>
                           <ce:para id="p0235" view="all">Yield 93%, white solid; m. p. 143–146 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.27 (s, 1H), 8.09–8.03 (m, 1H), 7.78 (dd, <ce:italic>J</ce:italic> = 7.6, 0.8 Hz, 1H), 7.44 (t, <ce:italic>J</ce:italic> = 7.8 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.5" view="all">
                           <ce:label>4.1.2.5</ce:label>
                           <ce:section-title id="sectitle0225">4-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3e</ce:bold>)</ce:section-title>
                           <ce:para id="p0240" view="all">Yield 90%, white solid; m. p. 213–216 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.97 (s, 1H), 7.96 (d, <ce:italic>J</ce:italic> = 3.9 Hz, 1H), 7.50 (dd, <ce:italic>J</ce:italic> = 7.6, 1.0 Hz, 1H), 7.48 (dd, <ce:italic>J</ce:italic> = 9.3, 4.4 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.6" view="all">
                           <ce:label>4.1.2.6</ce:label>
                           <ce:section-title id="sectitle0230">5-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3f</ce:bold>)</ce:section-title>
                           <ce:para id="p0245" view="all">Yield 95%, pink solid; m. p. 233–236 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.08–8.06 (m, 1H), 8.08–8.03 (m, 3H), 8.05 (d, <ce:italic>J</ce:italic> = 3.4 Hz, 1H), 7.50 (dd, <ce:italic>J</ce:italic> = 8.6, 2.1 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.7" view="all">
                           <ce:label>4.1.2.7</ce:label>
                           <ce:section-title id="sectitle0235">6-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3g</ce:bold>)</ce:section-title>
                           <ce:para id="p0250" view="all">Yield 94%, white solid; m. p. 113–116 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.12 (d, <ce:italic>J</ce:italic> = 1.8 Hz, 1H), 7.93 (t, <ce:italic>J</ce:italic> = 9.4 Hz, 1H), 7.89 (s, 1H), 7.43 (dd, <ce:italic>J</ce:italic> = 8.5, 2.0 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.8" view="all">
                           <ce:label>4.1.2.8</ce:label>
                           <ce:section-title id="sectitle0240">4-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3h</ce:bold>)</ce:section-title>
                           <ce:para id="p0255" view="all">Yield 95%, white solid; m. p. 238–240 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 13.72 (s, 1H), 8.05 (s, 1H), 7.91 (d, <ce:italic>J</ce:italic> = 8.2 Hz, 1H), 7.55 (td, <ce:italic>J</ce:italic> = 8.1, 5.2 Hz, 1H), 7.28 (dd, <ce:italic>J</ce:italic> = 10.3, 8.0 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.9" view="all">
                           <ce:label>4.1.2.9</ce:label>
                           <ce:section-title id="sectitle0245">6-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3i</ce:bold>)</ce:section-title>
                           <ce:para id="p0260" view="all">Yield 94%, orange solid; m. p. 193–196 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 13.30 (s, 1H), 8.11 (s, 1H), 8.05 (dd, <ce:italic>J</ce:italic> = 9.0, 5.3 Hz, 1H), 7.97 (dd, <ce:italic>J</ce:italic> = 9.4, 2.2 Hz, 1H), 7.35 (td, <ce:italic>J</ce:italic> = 9.0, 2.4 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.10" view="all">
                           <ce:label>4.1.2.10</ce:label>
                           <ce:section-title id="sectitle0250">4-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3j</ce:bold>)</ce:section-title>
                           <ce:para id="p0265" view="all">Yield 89%, white solid; m. p. 243–246 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 13.85 (s, 1H), 8.58 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 8.41 (d, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 8.04 (s, 1H), 7.76 (t, <ce:italic>J</ce:italic> = 8.0 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.11" view="all">
                           <ce:label>4.1.2.11</ce:label>
                           <ce:section-title id="sectitle0255">5-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3k</ce:bold>)</ce:section-title>
                           <ce:para id="p0270" view="all">Yield 75%, white solid; m. p. 145–146 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 13.70 (s, 1H), 8.85 (d, <ce:italic>J</ce:italic> = 2.2 Hz, 1H), 8.22 (d, <ce:italic>J</ce:italic> = 9.0 Hz, 1H), 8.18 (t, <ce:italic>J</ce:italic> = 2.7 Hz, 1H), 8.17 (d, <ce:italic>J</ce:italic> = 2.1 Hz, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.12" view="all">
                           <ce:label>4.1.2.12</ce:label>
                           <ce:section-title id="sectitle0260">6-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3l</ce:bold>)</ce:section-title>
                           <ce:para id="p0275" view="all">Yield 78%, brown solid; m. p. 161–164 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 13.93 (s, 1H), 8.26 (d, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 8.24 (dd, <ce:italic>J</ce:italic> = 12.7, 5.5 Hz, 1H), 7.56 (d, <ce:italic>J</ce:italic> = 8.2 Hz, 1H), 7.21–7.12 (m, 1H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.13" view="all">
                           <ce:label>4.1.2.13</ce:label>
                           <ce:section-title id="sectitle0265">4-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3<ce:italic>m</ce:italic>
                              </ce:bold>)</ce:section-title>
                           <ce:para id="p0280" view="all">Yield 91%, white solid; m. p. 199–201 °C;<ce:sup loc="post">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 13.46 (s, 1H), 8.01 (s, 1H), 7.60 (d, <ce:italic>J</ce:italic> = 8.2 Hz, 1H), 7.49 (t, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 6.98 (d, <ce:italic>J</ce:italic> = 7.9 Hz, 1H), 3.96 (s, 3H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.2.14" view="all">
                           <ce:label>4.1.2.14</ce:label>
                           <ce:section-title id="sectitle0270">6-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carboxylic acid (<ce:bold>3n</ce:bold>)</ce:section-title>
                           <ce:para id="p0285" view="all">Yield 93%, white solid; m. p. 143–146 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 13.25 (s, 1H), 8.01 (s, 1H), 7.89–7.84 (m, 1H), 7.60 (d, <ce:italic>J</ce:italic> = 2.3 Hz, 1H), 7.06 (dd, <ce:italic>J</ce:italic> = 8.8, 2.4 Hz, 1H), 3.84 (s, 3H).</ce:para>
                        </ce:section>
                     </ce:section>
                     <ce:section id="sec4.1.3" view="all">
                        <ce:label>4.1.3</ce:label>
                        <ce:section-title id="sectitle0275">General procedures for the preparation of <ce:bold>4a</ce:bold>-<ce:bold>4o</ce:bold>
                        </ce:section-title>
                        <ce:para id="p0290" view="all">To a solution of <ce:bold>3a</ce:bold>-<ce:bold>3o</ce:bold> (1.94 mmol) in anhydrous dichloromethane (20.0 mL) and HATU (2.33 mmol) in the presence of DIEA (3.89 mmol), tert-butylpiperazine-1-carboxylate (2.14 mmol) was added and stirred for 12 h. After completion, dilute hydrochloric acid solution was added, extracted with dichloromethane and washed with saturated sodium carbonate solution three times. The combined organic layers were washed with brine and dried with sodium sulfate, filtered, concentrated, and purified by silica gel chromatography with petroleum ether/ethyl acetate as eluent to give pure <ce:bold>4a</ce:bold>-<ce:bold>4o</ce:bold> [<ce:cross-ref refid="bib34" id="crosref0335">34</ce:cross-ref>]<ce:bold>
                              <ce:italic>.</ce:italic>
                           </ce:bold>
                        </ce:para>
                        <ce:section id="sec4.1.3.1" view="all">
                           <ce:label>4.1.3.1</ce:label>
                           <ce:section-title id="sectitle0280">Tert-butyl 4-(4-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4a</ce:bold>)</ce:section-title>
                           <ce:para id="p0295" view="all">Yield 93%, white solid; m. p. 113–116 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.81 (d, <ce:italic>J</ce:italic> = 8.1 Hz, 1H), 7.63 (s, 1H), 7.59 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 3.82–3.74 (m, 4H), 3.55 (s, 4H), 1.50 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.2" view="all">
                           <ce:label>4.1.3.2</ce:label>
                           <ce:section-title id="sectitle0285">Tert-butyl 4-(5-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4b</ce:bold>)</ce:section-title>
                           <ce:para id="p0300" view="all">Yield 95%, white solid; m. p. 148–151 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.15 (d, <ce:italic>J</ce:italic> = 1.8 Hz, 1H), 8.01 (t, <ce:italic>J</ce:italic> = 9.9 Hz, 1H), 7.72 (s, 1H), 7.59 (dt, <ce:italic>J</ce:italic> = 11.9, 5.9 Hz, 1H), 3.63 (d, <ce:italic>J</ce:italic> = 22.6 Hz, 4H), 3.43 (s, 4H), 1.42 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.3" view="all">
                           <ce:label>4.1.3.3</ce:label>
                           <ce:section-title id="sectitle0290">Tert-butyl 4-(6-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4c</ce:bold>)</ce:section-title>
                           <ce:para id="p0305" view="all">Yield 85%, white solid; m. p. 120–124 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.86 (t, <ce:italic>J</ce:italic> = 3.2 Hz, 1H), 7.74 (dd, <ce:italic>J</ce:italic> = 8.0, 1.6 Hz, 1H), 7.29 (dd, <ce:italic>J</ce:italic> = 18.6, 8.2 Hz, 2H), 3.61 (s, 4H), 3.51 (s, 4H), 1.47 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.4" view="all">
                           <ce:label>4.1.3.4</ce:label>
                           <ce:section-title id="sectitle0295">Tert-butyl 4-(7-bromobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4d</ce:bold>)</ce:section-title>
                           <ce:para id="p0310" view="all">Yield 84%, white solid; m. p. 156–158 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.77 (d, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 7.58 (d, <ce:italic>J</ce:italic> = 7.1 Hz, 1H), 7.56 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 7.29 (t, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 3.74 (t, <ce:italic>J</ce:italic> = 4.6 Hz, 4H), 3.52 (s, 4H), 1.48 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.5" view="all">
                           <ce:label>4.1.3.5</ce:label>
                           <ce:section-title id="sectitle0300">Tert-butyl 4-(4-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4e</ce:bold>)</ce:section-title>
                           <ce:para id="p0315" view="all">Yield 89%, white solid; m. p. 107–109 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.75 (t, <ce:italic>J</ce:italic> = 10.6 Hz, 1H), 7.63 (s, 1H), 7.40 (dd, <ce:italic>J</ce:italic> = 7.7, 0.6 Hz, 1H), 7.36–7.31 (m, 1H), 3.80–3.72 (m, 4H), 3.50 (d, <ce:italic>J</ce:italic> = 25.6 Hz, 4H), 1.48 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.6" view="all">
                           <ce:label>4.1.3.6</ce:label>
                           <ce:section-title id="sectitle0305">Tert-butyl 4-(5-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4f</ce:bold>)</ce:section-title>
                           <ce:para id="p0320" view="all">Yield 88%, white solid; m. p. 124–126 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.79 (d, <ce:italic>J</ce:italic> = 1.8 Hz, 1H), 7.76 (d, <ce:italic>J</ce:italic> = 8.6 Hz, 1H), 7.41 (s, 1H), 7.37 (dd, <ce:italic>J</ce:italic> = 8.6, 2.0 Hz, 1H), 3.73 (s, 4H), 3.47 (s, 4H), 1.47 (d, <ce:italic>J</ce:italic> = 8.2 Hz, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.7" view="all">
                           <ce:label>4.1.3.7</ce:label>
                           <ce:section-title id="sectitle0310">Tert-butyl 4-(6-chlorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4g</ce:bold>)</ce:section-title>
                           <ce:para id="p0325" view="all">Yield 65%, white solid; m. p. 119–121 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.83 (d, <ce:italic>J</ce:italic> = 0.6 Hz, 1H), 7.73 (d, <ce:italic>J</ce:italic> = 8.5 Hz, 1H), 7.44 (s, 1H), 7.37 (dd, <ce:italic>J</ce:italic> = 8.5, 1.2 Hz, 1H), 3.78–3.69 (m, 4H), 3.50 (d, <ce:italic>J</ce:italic> = 13.7 Hz, 4H), 1.48 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.8" view="all">
                           <ce:label>4.1.3.8</ce:label>
                           <ce:section-title id="sectitle0315">Tert-butyl 4-(4-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4h</ce:bold>)</ce:section-title>
                           <ce:para id="p0330" view="all">Yield 92%, yellow solid; m. p. 126–130 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.87 (dd, <ce:italic>J</ce:italic> = 15.5, 6.6 Hz, 1H), 7.76 (d, <ce:italic>J</ce:italic> = 0.5 Hz, 1H), 7.48 (t, <ce:italic>J</ce:italic> = 13.3, 6.7 Hz, 1H), 7.26 (dt, <ce:italic>J</ce:italic> = 13.9, 7.0 Hz, 1H), 3.67 (s, 4H), 3.43 (s, 4H),1.45 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.9" view="all">
                           <ce:label>4.1.3.9</ce:label>
                           <ce:section-title id="sectitle0320">Tert-butyl 4-(6-fluorobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4i</ce:bold>)</ce:section-title>
                           <ce:para id="p0335" view="all">Yield 94%, white solid; m. p. 155–157 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.96 (t, <ce:italic>J</ce:italic> = 3.2 Hz, 1H), 7.95 (s, 1H), 7.77 (s, 1H), 7.33 (td, <ce:italic>J</ce:italic> = 9.1, 2.2 Hz, 1H), 3.67 (s, 4H), 3.43 (s, 4H), 1.42 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.10" view="all">
                           <ce:label>4.1.3.10</ce:label>
                           <ce:section-title id="sectitle0325">Tert-butyl 4-(4-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4j</ce:bold>)</ce:section-title>
                           <ce:para id="p0340" view="all">Yield 88%, yellow solid; m. p. 120–122 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.56 (d, <ce:italic>J</ce:italic> = 8.1 Hz, 1H), 8.38 (t, <ce:italic>J</ce:italic> = 11.0 Hz, 1H), 8.22 (s, 1H), 7.75–7.67 (m, 1H), 3.71–3.63 (m, 4H), 3.44 (s, 4H), 1.41 (d, <ce:italic>J</ce:italic> = 8.1 Hz, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.11" view="all">
                           <ce:label>4.1.3.11</ce:label>
                           <ce:section-title id="sectitle0330">Tert-butyl 4-(5-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4k</ce:bold>)</ce:section-title>
                           <ce:para id="p0345" view="all">Yield 84%, white solid; m. p. 123–126 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 8.70 (d, <ce:italic>J</ce:italic> = 2.0 Hz, 1H), 8.24 (dd, <ce:italic>J</ce:italic> = 8.9, 2.2 Hz, 1H), 7.97 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 1H), 7.61 (s, 1H), 3.74 (s, 4H), 3.52 (s, 4H), 1.46 (d, <ce:italic>J</ce:italic> = 7.3 Hz, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.12" view="all">
                           <ce:label>4.1.3.12</ce:label>
                           <ce:section-title id="sectitle0335">Tert-butyl 4-(6-nitrobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4l</ce:bold>)</ce:section-title>
                           <ce:para id="p0350" view="all">Yield 89%, yellow solid; m. p. 144–146 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 9.13 (d, <ce:italic>J</ce:italic> = 1.7 Hz, 1H), 8.26 (dd, <ce:italic>J</ce:italic> = 8.8, 2.1 Hz, 1H), 8.14 (d, <ce:italic>J</ce:italic> = 8.8 Hz, 1H), 7.93 (s, 1H), 3.66 (s, 4H), 3.44 (s, 4H), 1.42 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.13" view="all">
                           <ce:label>4.1.3.13</ce:label>
                           <ce:section-title id="sectitle0340">Tert-butyl 4-(4-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4<ce:italic>m</ce:italic>
                              </ce:bold>)</ce:section-title>
                           <ce:para id="p0355" view="all">Yield 92%, orange solid; m. p. 92–96 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.66 (s, 1H), 7.56 (d, <ce:italic>J</ce:italic> = 8.1 Hz, 1H), 7.41 (t, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 6.95 (d, <ce:italic>J</ce:italic> = 7.9 Hz, 1H), 3.93 (s, 3H), 3.66 (s, 4H), 3.42 (s, 4H), 1.42 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.14" view="all">
                           <ce:label>4.1.3.14</ce:label>
                           <ce:section-title id="sectitle0345">Tert-butyl 4-(6-methoxybenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>4n</ce:bold>)</ce:section-title>
                           <ce:para id="p0360" view="all">Yield 71%, white solid; m. p. 103–106 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.64 (m, 1H), 7.40 (s, 1H), 7.28 (d, <ce:italic>J</ce:italic> = 2.2 Hz, 1H), 7.00 (dd, <ce:italic>J</ce:italic> = 8.8, 2.3 Hz, 1H), 3.86 (s, 3H), 3.78–3.70 (m, 4H), 3.53–3.46 (m, 4H), 1.47 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.3.15" view="all">
                           <ce:label>4.1.3.15</ce:label>
                           <ce:section-title id="sectitle0350">Tert-butyl 4-(benzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>4o</ce:bold>)</ce:section-title>
                           <ce:para id="p0365" view="all">Yield 92%, white solid; m. p. 136–138 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.89–7.78 (m, 2H), 7.48 (s, 1H), 7.43–7.37 (m, 2H), 3.78–3.70 (m, 4H), 3.51 (s, 4H), 1.47 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 9H).</ce:para>
                        </ce:section>
                     </ce:section>
                     <ce:section id="sec4.1.4" view="all">
                        <ce:label>4.1.4</ce:label>
                        <ce:section-title id="sectitle0355">General procedures for the preparation of <ce:bold>5a</ce:bold>-<ce:bold>5o</ce:bold> and <ce:bold>8</ce:bold>
                        </ce:section-title>
                        <ce:para id="p0370" view="all">3-Chloroperbenzoic acid (2.5 mmol) was added to the stirred solution of compound <ce:bold>4a</ce:bold>-<ce:bold>4o</ce:bold> and benzo [<ce:italic>b</ce:italic>]thiophene (1.0 mmol) in dichloromethane (20 mL) in portions over a 20–30 min period. The mixture was heated to reflux for about 5 h and monitored by TLC. After completion, the mixture was cooled to room temperature and sodium hydrogen sulfite (20 mL) was added. The solution was stirred for 15 min and extracted with dichloromethane. The organic phase was washed with aqueous sodium bicarbonate (2 × 10 mL). The organic phase was separated, washed with brine and dried with sodium sulfate, filtered, and the solvents were removed under reduced pressure to give the sulfone compound <ce:bold>5a</ce:bold>-<ce:bold>5o</ce:bold> and <ce:bold>8</ce:bold> [<ce:cross-ref refid="bib31" id="crosref0340">31</ce:cross-ref>,<ce:cross-ref refid="bib34" id="crosref0345">34</ce:cross-ref>].</ce:para>
                        <ce:section id="sec4.1.4.1" view="all">
                           <ce:label>4.1.4.1</ce:label>
                           <ce:section-title id="sectitle0360">Tert-butyl 4-(4-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5a</ce:bold>)</ce:section-title>
                           <ce:para id="p0375" view="all">Yield 84%, white solid; m. p. 178–180 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.98 (dd, <ce:italic>J</ce:italic> = 7.8, 5.6 Hz, 2H), 7.79 (d, <ce:italic>J</ce:italic> = 0.7 Hz, 1H), 7.65–7.61 (m, 1H), 3.57 (d, <ce:italic>J</ce:italic> = 13.1 Hz, 4H), 3.45–3.35 (m, 4H), 1.41 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.2" view="all">
                           <ce:label>4.1.4.2</ce:label>
                           <ce:section-title id="sectitle0365">Tert-butyl 4-(5-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5b</ce:bold>)</ce:section-title>
                           <ce:para id="p0380" view="all">Yield 79%, white solid; m. p. 138–141 °C; <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.93 (d, <ce:italic>J</ce:italic> = 8.3 Hz, 1H), 7.91 (t, <ce:italic>J</ce:italic> = 4.0 Hz, 2H), 7.74 (s, 1H), 3.57 (s, 4H), 3.39 (s, 4H), 1.41 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.3" view="all">
                           <ce:label>4.1.4.3</ce:label>
                           <ce:section-title id="sectitle0370">Tert-butyl 4-(6-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5c</ce:bold>)</ce:section-title>
                           <ce:para id="p0385" view="all">Yield 85%, white solid; m. p. 156–158 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.86 (t, <ce:italic>J</ce:italic> = 3.2 Hz, 1H), 7.74 (dd, <ce:italic>J</ce:italic> = 8.0, 1.6 Hz, 1H), 7.29 (dd, <ce:italic>J</ce:italic> = 18.6, 8.2 Hz, 2H), 3.61 (d, <ce:italic>J</ce:italic> = 56.7 Hz, 4H), 3.51 (dd, <ce:italic>J</ce:italic> = 15.2, 10.5 Hz, 4H), 1.49–1.45 (m, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.4" view="all">
                           <ce:label>4.1.4.4</ce:label>
                           <ce:section-title id="sectitle0375">Tert-butyl 4-(7-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5d</ce:bold>)</ce:section-title>
                           <ce:para id="p0390" view="all">Yield 71%, white solid; m. p. 127–129 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.86 (dd, <ce:italic>J</ce:italic> = 7.4, 1.5 Hz, 1H), 7.77 (s, 1H), 7.66 (qd, <ce:italic>J</ce:italic> = 7.5, 2.3 Hz, 1H), 3.57 (s, 4H), 3.38 (s, 4H), 1.41 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.5" view="all">
                           <ce:label>4.1.4.5</ce:label>
                           <ce:section-title id="sectitle0380">Tert-butyl 4-(4-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5e</ce:bold>)</ce:section-title>
                           <ce:para id="p0395" view="all">Yield 47%, white solid; m. p. 117–119 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.64 (d, <ce:italic>J</ce:italic> = 7.4 Hz, 1H), 7.59 (d, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 7.53 (dd, <ce:italic>J</ce:italic> = 8.7, 6.8 Hz, 2H), 3.68 (s, 4H), 3.56–3.50 (m, 4H), 1.47 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.6" view="all">
                           <ce:label>4.1.4.6</ce:label>
                           <ce:section-title id="sectitle0385">Tert-butyl 4-(5-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5f</ce:bold>)</ce:section-title>
                           <ce:para id="p0400" view="all">Yield 47%, white solid; m. p. 183–186 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.67 (d, <ce:italic>J</ce:italic> = 8.1 Hz, 1H), 7.58–7.51 (m, 1H), 7.42 (d, <ce:italic>J</ce:italic> = 1.6 Hz, 1H), 7.23 (d, <ce:italic>J</ce:italic> = 12.8 Hz, 1H), 3.60 (s, 4H), 3.51 (s, 4H), 1.47 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.7" view="all">
                           <ce:label>4.1.4.7</ce:label>
                           <ce:section-title id="sectitle0390">Tert-butyl 4-(6-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carboxylate (<ce:bold>5g</ce:bold>)</ce:section-title>
                           <ce:para id="p0405" view="all">Yield 53%, white solid; m. p. 132–134 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.71–7.69 (m, 1H), 7.56 (dt, <ce:italic>J</ce:italic> = 9.4, 4.7 Hz, 1H), 7.37 (d, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 7.28 (d, <ce:italic>J</ce:italic> = 11.7 Hz, 1H), 3.66 (s, 4H), 3.54–3.48 (m, 4H), 1.46 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.8" view="all">
                           <ce:label>4.1.4.8</ce:label>
                           <ce:section-title id="sectitle0395">Tert-butyl 4-(4-fluoro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5h</ce:bold>)</ce:section-title>
                           <ce:para id="p0410" view="all">Yield 85%, white soild; m. p. 203–206 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.91 (d, <ce:italic>J</ce:italic> = 7.9 Hz, 1H), 7.82 (d, <ce:italic>J</ce:italic> = 7.5 Hz, 1H), 7.76 (td, <ce:italic>J</ce:italic> = 7.9, 4.7 Hz, 1H), 7.65 (t, <ce:italic>J</ce:italic> = 8.7 Hz, 1H), 3.58 (s, 4H), 3.39 (s, 4H), 1.41 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.9" view="all">
                           <ce:label>4.1.4.9</ce:label>
                           <ce:section-title id="sectitle0400">4-(6-Fluoro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5i</ce:bold>)</ce:section-title>
                           <ce:para id="p0415" view="all">Yield 91%, white solid; m. p. 163–166 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.07 (dd, <ce:italic>J</ce:italic> = 7.1, 2.1 Hz, 1H), 7.84 (s, 1H), 7.77 (dd, <ce:italic>J</ce:italic> = 8.4, 4.7 Hz, 1H), 7.64 (td, <ce:italic>J</ce:italic> = 8.8, 2.4 Hz, 1H), 3.60 (s, 4H), 3.42 (s, 4H), 1.44 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.10" view="all">
                           <ce:label>4.1.4.10</ce:label>
                           <ce:section-title id="sectitle0405">4-(4-Nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5j</ce:bold>)</ce:section-title>
                           <ce:para id="p0420" view="all">Yield 49%, yellow solid; m. p. 163–166 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.43 (dd, <ce:italic>J</ce:italic> = 8.3, 0.6 Hz, 1H), 8.38 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 8.18 (d, <ce:italic>J</ce:italic> = 0.5 Hz, 1H), 7.93 (dd, <ce:italic>J</ce:italic> = 14.4, 6.5 Hz, 1H), 3.58 (d, <ce:italic>J</ce:italic> = 30.5 Hz, 4H), 3.41 (d, <ce:italic>J</ce:italic> = 23.1 Hz, 4H), 1.41 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.11" view="all">
                           <ce:label>4.1.4.11</ce:label>
                           <ce:section-title id="sectitle0410">Tert-butyl 4-(5-nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5k</ce:bold>)</ce:section-title>
                           <ce:para id="p0425" view="all">Yield 58%, white solid; m. p. 118–121 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 8.47 (dd, <ce:italic>J</ce:italic> = 8.2, 1.9 Hz, 1H), 8.33–8.24 (m, 1H), 7.92 (dd, <ce:italic>J</ce:italic> = 21.5, 8.3 Hz, 1H), 7.43–7.33 (m, 1H), 3.82–3.47 (m, 8H), 1.58–1.37 (m, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.12" view="all">
                           <ce:label>4.1.4.12</ce:label>
                           <ce:section-title id="sectitle0415">4-(6-Nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5l</ce:bold>)</ce:section-title>
                           <ce:para id="p0430" view="all">Yield 51%, yellow solid; m. p. 160–161 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.92 (d, <ce:italic>J</ce:italic> = 0.6 Hz, 1H), 7.82 (d, <ce:italic>J</ce:italic> = 7.5 Hz, 1H), 7.79–7.73 (m, 1H), 7.65 (t, <ce:italic>J</ce:italic> = 8.6 Hz, 1H), 3.58 (s, 4H), 3.39 (s, 4H), 1.41 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.13" view="all">
                           <ce:label>4.1.4.13</ce:label>
                           <ce:section-title id="sectitle0420">Tert-butyl 4-(4-methoxy-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5<ce:italic>m</ce:italic>
                              </ce:bold>)</ce:section-title>
                           <ce:para id="p0435" view="all">Yield 91%, yellow solid; m. p. 143–146 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.77 (s, 1H), 7.70–7.65 (m, 1H), 7.46 (d, <ce:italic>J</ce:italic> = 7.5 Hz, 1H), 7.42 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 3.94 (s, 3H), 3.55 (s, 4H), 3.39 (s, 4H), 1.41 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.14" view="all">
                           <ce:label>4.1.4.14</ce:label>
                           <ce:section-title id="sectitle0425">Tert-butyl 4-(6-methoxy-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5n</ce:bold>)</ce:section-title>
                           <ce:para id="p0440" view="all">Yield 71%, white solid; m. p. 115–116 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.35 (t, <ce:italic>J</ce:italic> = 6.5 Hz, 1H), 7.32 (s, 1H), 7.30–7.28 (m, 1H), 7.08 (dt, <ce:italic>J</ce:italic> = 7.4, 3.7 Hz, 1H), 3.92 (s, 3H), 3.70 (m, 4H), 3.53 (m, 4H), 1.49 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.15" view="all">
                           <ce:label>4.1.4.15</ce:label>
                           <ce:section-title id="sectitle0430">Tert-butyl 4-(1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carboxylate (<ce:bold>5o</ce:bold>)</ce:section-title>
                           <ce:para id="p0445" view="all">Yield 66%, white solid; m. p. 99–102 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, CDCl<ce:inf loc="post">3</ce:inf>) <ce:italic>δ</ce:italic> 7.74 (t, <ce:italic>J</ce:italic> = 9.9 Hz, 1H), 7.64–7.54 (m, 2H), 7.44 (t, <ce:italic>J</ce:italic> = 9.9 Hz, 1H), 7.30 (s, 1H), 3.67 (s, 4H), 3.56–3.47 (m, 4H), 1.46 (s, 9H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.4.16" view="all">
                           <ce:label>4.1.4.16</ce:label>
                           <ce:section-title id="sectitle0435">benzo[<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide (<ce:bold>8</ce:bold>)</ce:section-title>
                           <ce:para id="p0450" view="all">Yield 72%, white solid; m. p. 140–141 °C; IR (KBr) <ce:italic>ν</ce:italic> 3418, 1620, 1550, 1448, 1287, 1193, 1150, 1122, 867, 752, 696, 625, 550, 520; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.86–7.83 (m, 1H), 7.72–7.67 (m, 1H), 7.65–7.63 (m, 1H), 7.61 (dd, <ce:italic>J</ce:italic> = 11.2, 4.1 Hz, 2H), 7.38 (d, <ce:italic>J</ce:italic> = 6.9 Hz, 1H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 136.33, 134.12, 132.92, 131.17, 131.16, 130.93, 126.04, 121.08; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 188.9979 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 188.9981, C<ce:inf loc="post">8</ce:inf>H<ce:inf loc="post">6</ce:inf>NaO<ce:inf loc="post">2</ce:inf>S).</ce:para>
                        </ce:section>
                     </ce:section>
                     <ce:section id="sec4.1.5" view="all">
                        <ce:label>4.1.5</ce:label>
                        <ce:section-title id="sectitle0440">General procedures for the preparation of <ce:bold>6</ce:bold>
                        </ce:section-title>
                        <ce:para id="p0455" view="all">4-(Diethylamino)-2-hydroxybenzaldehyde (25.87 mmol) and diethyl malonate (5.89 mL, 38.81 mmol) were dissolved in anhydrous enthanol (50 mL), and then piperidine (5.17 mmol, 512 μL) was added. The reaction mixture was refluxed for 12 h, and then the solvents were removed under reduced pressure, water (50 mL) was added and the mixture was extracted with ethyl acetate (2 × 40 mL). The combined organic layers were dried with sodium sulfate, filtered, and the solvents were removed under reduced pressure to afford the ethyl ester.</ce:para>
                        <ce:para id="p0460" view="all">The ethyl ester was dissolved in 2 M sodium hydroxide solution (40 mL) and was stirred at room temperature for 12 h. The solution was acidified with 2 M hydrochloric acid solution, then the precipitate was collected and washed with water to afford compound <ce:bold>6</ce:bold> [<ce:cross-ref refid="bib56" id="crosref0350">56</ce:cross-ref>]<ce:bold>.</ce:bold>
                        </ce:para>
                        <ce:section id="sec4.1.5.1" view="all">
                           <ce:label>4.1.5.1</ce:label>
                           <ce:section-title id="sectitle0445">Ethyl 7-(diethylamino)-2-oxo-2H-chromene-3-carboxylate</ce:section-title>
                           <ce:para id="p0465" view="all">Yield 84%, brown oil; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.54 (s, 1H), 7.62 (d, <ce:italic>J = </ce:italic>9.0 Hz, 1H), 6.76 (d, <ce:italic>J = </ce:italic>9.0 Hz, 1H), 6.53 (s, 1H), 4.22 (q, <ce:italic>J = </ce:italic>7.1 Hz, 2H), 3.47 (q, <ce:italic>J = </ce:italic>6.9 Hz, 4H), 1.28 (t, <ce:italic>J = </ce:italic>7.1 Hz, 3H), 1.12 (t, <ce:italic>J = </ce:italic>7.0 Hz, 6H).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.5.2" view="all">
                           <ce:label>4.1.5.2</ce:label>
                           <ce:section-title id="sectitle0450">7-(diethylamino)-2-oxo-2H-chromene-3-carboxylic acid (6)</ce:section-title>
                           <ce:para id="p0470" view="all">Yield 72%, orange solid; m. p. 223–226 °C; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 12.51 (s, 1H), 8.58 (s, 1H), 7.63 (d, <ce:italic>J = </ce:italic>9.0 Hz, 1H), 6.78 (dd, <ce:italic>J = </ce:italic>9.0, 2.3 Hz, 1H), 6.56 (d, <ce:italic>J = </ce:italic>2.2 Hz, 1H), 3.48 (q, <ce:italic>J = </ce:italic>7.0 Hz, 4H), 1.13 (t, <ce:italic>J = </ce:italic>7.1 Hz, 6H).</ce:para>
                        </ce:section>
                     </ce:section>
                     <ce:section id="sec4.1.6" view="all">
                        <ce:label>4.1.6</ce:label>
                        <ce:section-title id="sectitle0455">General procedures for the preparation of <ce:bold>7a</ce:bold>-<ce:bold>7o</ce:bold>
                        </ce:section-title>
                        <ce:para id="p0475" view="all">To a solution of <ce:bold>5a</ce:bold>-<ce:bold>5o</ce:bold> (1.0 mmol) in DCM (4 mL) was added TFA (1 mL) at 0 °C. The reaction mixture was stirred at room temperature for 2 h and then the solvents were removed under reduced pressure. The crude mixture was used as such (without further purification) in the following step. The crude <ce:italic>N</ce:italic>-Boc deprotected compound (2.11 mmol) was dissolved in anhydrous dichloromethane (10 mL) and HATU (2.29 mmol) in the presence of DIEA (7.65 mmol), compound <ce:bold>6</ce:bold> (1.91 mmol) was added and stirred for 12 h. After completion, dilute hydrochloric acid solution was added and extracted with dichloromethane, washed with saturated sodium carbonate solution three times. The combined organic layers were washed with brine and dried with sodium sulfate, filtered, concentrated, and purified by silica gel chromatography with petroleum ether/ethyl acetate as eluent to give pure <ce:bold>7a</ce:bold>-<ce:bold>7o<ce:italic>.</ce:italic>
                           </ce:bold>
                        </ce:para>
                        <ce:section id="sec4.1.6.1" view="all">
                           <ce:label>4.1.6.1</ce:label>
                           <ce:section-title id="sectitle0460">3-(4-(4-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7a</ce:bold>)</ce:section-title>
                           <ce:para id="p0480" view="all">Yield 71%, yellow solid; m. p. 154–156 °C; IR (KBr) <ce:italic>ν</ce:italic> 3443, 2926, 1711, 1619, 1517, 1444, 1353, 1316, 1224, 1169, 1132, 788, 546 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.02 (s, 1H), 7.98 (d, <ce:italic>J</ce:italic> = 6.2 Hz, 2H), 7.84 (s, 1H), 7.63 (t, <ce:italic>J</ce:italic> = 7.4 Hz, 1H), 7.50 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 1H), 6.75 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 6.56 (s, 1H), 3.75–3.38 (m, 8H), 3.45 (q, <ce:italic>J</ce:italic> = 6.6 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 6.6 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.36, 158.50, 157.45, 156.69, 151.33, 144.28, 137.81, 137.45, 137.35, 133.57, 130.21, 129.91, 129.10, 120.88, 120.83, 115.53, 109.44, 107.14, 96.29, 59.77, 44.19, 12.31; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 622.0623 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 622.0618, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>BrN<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.2" view="all">
                           <ce:label>4.1.6.2</ce:label>
                           <ce:section-title id="sectitle0465">3-(4-(5-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7b</ce:bold>)</ce:section-title>
                           <ce:para id="p0485" view="all">Yield 69%, yellow solid; m. p. 169–171 °C; IR (KBr) <ce:italic>ν</ce:italic> 3423, 2922, 1707, 1621, 1518, 1416, 1354, 1306, 1226, 1192, 1154, 1132, 1062, 994, 815, 577 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.53 (s, 1H), 8.44 (d, <ce:italic>J</ce:italic> = 24.8 Hz, 3H), 8.30 (s, 1H), 8.02 (d, <ce:italic>J</ce:italic> = 8.8 Hz, 1H), 7.26 (d, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 7.07 (s, 1H), 4.29–3.84 (m, 8H), 3.95 (q, <ce:italic>J</ce:italic> = 6.8 Hz, 4H), 1.64 (t, <ce:italic>J</ce:italic> = 6.8 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.37, 158.50, 157.60, 156.70, 151.34, 144.31, 136.90, 134.54, 134.27, 131.61, 130.93, 130.21, 129.88, 127.70, 123.22, 115.48, 109.44, 107.13, 96.29, 59.77, 44.19, 12.31; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 622.0618 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 622.0618, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>BrN<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.3" view="all">
                           <ce:label>4.1.6.3</ce:label>
                           <ce:section-title id="sectitle0470">3-(4-(6-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7c</ce:bold>)</ce:section-title>
                           <ce:para id="p0490" view="all">Yield 72%, yellow solid; m. p. 155–157 °C; IR (KBr) <ce:italic>ν</ce:italic> 3423, 2921, 1710, 1621, 1516, 1415, 1353, 1313, 1224, 1153, 1313, 1224, 1153, 1131, 1073, 993, 809, 606, 548, 419 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (500 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.30 (s, 1H), 8.02 (s, 1H), 7.97 (d, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 7.84 (s, 1H), 7.63 (d, <ce:italic>J</ce:italic> = 7.9 Hz, 1H), 7.50 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 1H), 6.75 (dd, <ce:italic>J</ce:italic> = 8.9, 2.2 Hz, 1H), 6.56 (d, <ce:italic>J</ce:italic> = 1.9 Hz, 1H), 3.73–3.55 (m, 8H), 3.45 (dd, <ce:italic>J</ce:italic> = 6.8 Hz, 4H), 1.13 (t, <ce:italic>J</ce:italic> = 7.0 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.43, 158.55, 157.75, 156.73, 151.38, 144.41, 137.34, 137.28, 135.75, 131.62, 130.26, 128.78, 128.48, 125.04, 124.68, 115.50, 109.48, 107.16, 96.31, 59.81, 44.23, 12.33; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 622.0614 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 622.0618, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>BrN<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.4" view="all">
                           <ce:label>4.1.6.4</ce:label>
                           <ce:section-title id="sectitle0475">3-(4-(7-bromo-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7d</ce:bold>)</ce:section-title>
                           <ce:para id="p0495" view="all">Yield 76%, yellow solid; m. p. 137–138 °C; IR (KBr) <ce:italic>ν</ce:italic> 3437, 2922, 1712, 1620, 1517, 1415, 1353, 1317, 1261, 1224, 1152, 1131, 803, 584, 548 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.02 (s, 1H), 7.86 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 7.81 (s, 1H), 7.66 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 2H), 7.50 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 1H), 6.75 (d, <ce:italic>J</ce:italic> = 7.4 Hz, 1H), 6.56 (s, 1H), 3.74–3.37 (m, 8H), 3.45 (q, <ce:italic>J</ce:italic> = 6.9 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 6.9 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.38, 158.51, 157.60, 156.71, 151.35, 144.22, 136.09, 135.09, 134.21, 132.48, 130.79, 130.22, 129.62, 126.30, 115.48, 115.40, 109.45, 107.14, 96.29, 59.77, 44.20, 12.31; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 622.0616 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 622.0618, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>BrN<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.5" view="all">
                           <ce:label>4.1.6.5</ce:label>
                           <ce:section-title id="sectitle0480">3-(4-(4-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7e</ce:bold>)</ce:section-title>
                           <ce:para id="p0500" view="all">Yield 74%, yellow solid; m. p. 145–146 °C; IR (KBr) <ce:italic>ν</ce:italic> 3472, 2974, 2926, 1711, 1622, 1517, 1417, 1354, 1310, 1275, 1245, 1191, 1132, 994, 843, 792, 546 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.02 (s, 1H), 7.95 (d, <ce:italic>J</ce:italic> = 12.4 Hz, 2H), 7.85 (d, <ce:italic>J = </ce:italic>7.4 Hz, 1H), 7.71 (t, <ce:italic>J</ce:italic> = 7.5 Hz, 1H), 7.50 (d, <ce:italic>J = </ce:italic>8.9 Hz, 1H), 6.75 (d, <ce:italic>J = </ce:italic>8.4 Hz, 1H), 6.56 (s, 1H), 3.72–3.40 (m, 8H), 3.45 (q, <ce:italic>J = </ce:italic>6.7 Hz, 4H), 1.12 (t, <ce:italic>J = </ce:italic>6.7 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.82, 158.96, 157.93, 157.15, 151.79, 144.71, 137.71, 137.53, 135.24, 133.99, 131.58, 130.67, 128.45, 127.73, 120.87, 115.97, 109.90, 107.59, 96.75, 60.23, 44.55, 12.77; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 578.1126 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 578.1123, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>ClN<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.6" view="all">
                           <ce:label>4.1.6.6</ce:label>
                           <ce:section-title id="sectitle0485">3-(4-(5-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7f</ce:bold>)</ce:section-title>
                           <ce:para id="p0505" view="all">Yield 71%, yellow solid; m. p. 150–151 °C; IR (KBr) <ce:italic>ν</ce:italic> 3421, 2922, 2852, 1713, 1621, 1517, 1416, 1310, 1227, 1156, 1132, 1080, 994, 817, 419 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.21 (s, 1H), 8.02 (s, 1H), 7.86 (s, 1H), 7.83 (d, <ce:italic>J</ce:italic> = 7.5 Hz, 1H), 7.71 (s, 1H), 7.50 (d, <ce:italic>J</ce:italic> = 8.8 Hz, 1H), 6.75 (d, <ce:italic>J</ce:italic> = 8.6 Hz, 1H), 6.56 (s, 1H), 3.54–3.43 (m, 8H), 3.45 (q, <ce:italic>J</ce:italic> = 6.7 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 6.8 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.38, 158.51, 157.61, 156.71, 151.35(s), 144.35, 138.93, 137.11, 134.11, 131.64, 131.38, 130.90, 130.22, 127.05, 123.17, 115.49, 109.45, 107.14, 96.29, 59.77, 44.20, 12.31; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 578.1125 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 578.1123, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>ClN<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.7" view="all">
                           <ce:label>4.1.6.7</ce:label>
                           <ce:section-title id="sectitle0490">3-(4-(6-chloro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-7-(diethylamino)-2H-chromen-2-one (<ce:bold>7g</ce:bold>)</ce:section-title>
                           <ce:para id="p0510" view="all">Yield 76%, yellow solid; m. p. 144–146 °C; IR (KBr) <ce:italic>ν</ce:italic> 3437, 2923, 1853, 1712, 1620, 1517, 1415, 1353, 1314, 1225, 1154, 1132, 1093, 993, 814, 549 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.02 (s, 1H), 8.00 (d, <ce:italic>J</ce:italic> = 8.0 Hz, 1H), 7.78 (dd, <ce:italic>J</ce:italic> = 21.9, 11.2 Hz, 3H), 7.50 (d, <ce:italic>J</ce:italic> = 8.8 Hz, 1H), 6.75 (d, <ce:italic>J</ce:italic> = 7.7 Hz, 1H), 6.56 (s, 1H), 3.74–3.38 (m, 8H), 3.45 (q, <ce:italic>J</ce:italic> = 6.9 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 6.9 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.37, 158.50, 157.71, 156.69, 151.33, 144.30, 137.21, 136.61, 135.98, 134.36, 131.48, 130.21, 128.53, 128.09, 122.04, 115.48, 109.44, 107.13, 96.28, 59.77, 44.79, 12.20; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 578.1121 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 578.1123, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>ClN<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.8" view="all">
                           <ce:label>4.1.6.8</ce:label>
                           <ce:section-title id="sectitle0495">7-(diethylamino)-3-(4-(4-fluoro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7h</ce:bold>)</ce:section-title>
                           <ce:para id="p0515" view="all">Yield 76%, yellow solid; m. p. 175–178 °C; IR (KBr) <ce:italic>ν</ce:italic> 2969, 1694, 1618, 1518, 1414, 1355, 1315, 1225, 1132, 995, 899, 795, 742, 595 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.02 (s, 1H), 7.96 (s, 1H), 7.82 (s, 1H), 7.76 (s, 1H), 7.65 (s, 1H), 7.50 (d, <ce:italic>J</ce:italic> = 8.1 Hz, 1H), 6.75 (d, <ce:italic>J</ce:italic> = 7.7 Hz, 1H), 6.56 (s, 1H), 3.64–3.45 (m, 8H), 3.61 (q, <ce:italic>J</ce:italic> = 6.8 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 6.8 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.36, 158.50, 158.01, 157.59, 156.69, 156.30, 151.34, 144.30, 137.15, 136.07, 134.64, 134.59, 130.22, 125.85, 122.03, 121.90, 118.00, 115.49, 109.45, 107.13, 96.29, 44.20, 12.32; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 562.1420 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 562.1419, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>FN<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.9" view="all">
                           <ce:label>4.1.6.9</ce:label>
                           <ce:section-title id="sectitle0500">7-(diethylamino)-3-(4-(6-fluoro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7i</ce:bold>)</ce:section-title>
                           <ce:para id="p0520" view="all">Yield 78%, yellow solid; m. p. 127–129 °C; IR (KBr) <ce:italic>ν</ce:italic> 2971, 2926, 1712, 1619, 1518, 1416, 1354, 1315, 1224, 1149, 1077, 994, 821, 739, 552 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.05 (s, 1H), 8.02 (s, 1H), 7.86 (s, 1H), 7.75 (s, 1H), 7.62 (s, 1H), 7.50 (d, <ce:italic>J</ce:italic> = 8.4 Hz, 1H), 6.75 (d, <ce:italic>J</ce:italic> = 7.8 Hz, 1H), 6.56 (s, 1H), 3.66–3.45 (m, 8H), 3.61 (q, <ce:italic>J</ce:italic> = 7.0 Hz, 4H), 1.13 (t, <ce:italic>J</ce:italic> = 7.0 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.82, 158.95, 158.22, 157.15, 151.80, 144.71, 138.13, 136.57, 132.13, 130.67, 129.67, 125.96, 121.80, 115.95, 110.94, 110.75, 109.90, 107.59, 96.75, 60.23, 44.65, 12.77; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 562.1417 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 562.1419, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>FN<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.10" view="all">
                           <ce:label>4.1.6.10</ce:label>
                           <ce:section-title id="sectitle0505">7-(diethylamino)-3-(4-(4-nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7j</ce:bold>)</ce:section-title>
                           <ce:para id="p0525" view="all">Yield 79%, red solid; m. p. 143–146 °C; IR (KBr) <ce:italic>ν</ce:italic> 2927, 1713, 1620, 1518, 1416, 1351, 1319, 1224, 1192, 1158, 1133, 1077, 995, 886, 845, 740, 539 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.02 (s, 1H), 7.97 (s, 1H), 7.82 (d, <ce:italic>J</ce:italic> = 6.9 Hz, 1H), 7.76 (d, <ce:italic>J</ce:italic> = 3.1 Hz, 1H), 7.69–7.62 (m, 1H), 7.51 (d, <ce:italic>J</ce:italic> = 8.7 Hz, 1H), 3.66–3.45 (m, 8H), 3.62 (q, <ce:italic>J</ce:italic> = 6.7 Hz, 4H), 1.13 (t, <ce:italic>J</ce:italic> = 6.4 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.81, 158.96, 158.04, 157.15, 151.79, 144.77, 137.58, 136.52, 135.09, 130.67, 126.31, 122.49, 122.36, 118.46, 115.94, 109.90, 107.59, 99.99, 96.74, 55.39, 44.65, 12.77; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 565.1395 [<ce:italic>M</ce:italic> − H]<ce:sup loc="post">-</ce:sup> (calcd for 565.1399, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">25</ce:inf>N<ce:inf loc="post">4</ce:inf>O<ce:inf loc="post">8</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.11" view="all">
                           <ce:label>4.1.6.11</ce:label>
                           <ce:section-title id="sectitle0510">7-(diethylamino)-3-(4-(5-nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7k</ce:bold>)</ce:section-title>
                           <ce:para id="p0530" view="all">Yield 76%, red solid; m. p. 154–156 °C; IR (KBr) <ce:italic>ν</ce:italic> 3438, 2922, 2852, 1712, 1621, 1517, 1416, 1352, 1319, 1225, 1154, 1132, 994, 808, 740, 589 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.60–8.42 (m, 2H), 8.26 (d, <ce:italic>J</ce:italic> = 7.6 Hz, 1H), 8.03 (s, 1H), 7.97 (s, 1H), 7.50 (d, <ce:italic>J</ce:italic> = 8.8 Hz, 1H), 6.75 (d, <ce:italic>J</ce:italic> = 8.3 Hz, 1H), 6.56 (s, 1H), 3.80–3.39 (m, 8H), 3.49 (q, <ce:italic>J</ce:italic> = 6.1 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 6.1 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.39, 158.50, 157.33, 156.71, 151.35, 151.19, 144.35, 140.02, 137.25, 131.41, 130.81, 130.22, 129.65, 127.20, 122.92, 115.45, 109.45, 107.13, 96.29, 59.77, 44.19, 12.30; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 589.1363 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 589.1364, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>N<ce:inf loc="post">4</ce:inf>NaO<ce:inf loc="post">8</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.12" view="all">
                           <ce:label>4.1.6.12</ce:label>
                           <ce:section-title id="sectitle0515">7-(diethylamino)-3-(4-(6-nitro-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7l</ce:bold>)</ce:section-title>
                           <ce:para id="p0535" view="all">Yield 80%, red solid; m. p. 168–170 °C; IR (KBr) <ce:italic>ν</ce:italic> 2969, 1692, 1601, 1519, 1429, 1357, 1315, 1242, 1154, 1079, 997, 900, 830, 795, 742, 596 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.43 (s, 1H), 8.38 (s, 1H), 8.24 (s, 1H), 8.02 (s, 1H), 7.94 (s, 1H), 7.50 (s, 1H), 6.75 (s, 1H), 6.56 (s, 1H), 3.69–3.45 (m, 8H), 3.64 (q, <ce:italic>J</ce:italic> = 6.4 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 6.4 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.65, 158.97, 157.59, 157.16, 151.80, 146.92, 144.55, 138.85, 137.57, 133.52, 130.67, 129.98, 128.86, 127.08, 123.20, 116.08, 109.90, 107.60, 96.74, 63.20, 44.65, 12.77; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 589.1364 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 589.1364, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">26</ce:inf>N<ce:inf loc="post">4</ce:inf>NaO<ce:inf loc="post">8</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.13" view="all">
                           <ce:label>4.1.6.13</ce:label>
                           <ce:section-title id="sectitle0520">7-(diethylamino)-3-(4-(4-methoxy-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl)piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7<ce:italic>m</ce:italic>
                              </ce:bold>)</ce:section-title>
                           <ce:para id="p0540" view="all">Yield 71%, yellow solid; m. p. 133–135 °C; IR (KBr) <ce:italic>ν</ce:italic> 2928, 1712, 1619, 1518, 1415, 1353, 1308, 1277, 1225, 1133, 1035, 99, 783, 738, 540 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 7.99 (s, 1H), 7.82 (s, 1H), 7.68 (d, <ce:italic>J</ce:italic> = 7.4 Hz, 1H), 7.50 (d, <ce:italic>J</ce:italic> = 8.7 Hz, 1H), 7.46 (d, <ce:italic>J</ce:italic> = 6.5 Hz, 1H), 7.42 (d, <ce:italic>J</ce:italic> = 7.7 Hz, 1H), 6.75 (d, <ce:italic>J</ce:italic> = 7.9 Hz, 1H), 6.56 (s, 1H), 3.94 (s, 3H), 3.65–3.45 (m, 8H), 3.59 (q, <ce:italic>J</ce:italic> = 6.5 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 6.5 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.79, 158.95, 158.52, 157.14, 155.63, 151.78, 144.69, 137.17, 134.91, 134.51, 130.66, 128.08, 118.19, 116.93, 116.01, 113.67, 109.89, 107.59, 96.75, 60.23, 56.89, 44.65, 12.77; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 574.1620 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 574.1618, C<ce:inf loc="post">28</ce:inf>H<ce:inf loc="post">29</ce:inf>N<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">7</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.14" view="all">
                           <ce:label>4.1.6.14</ce:label>
                           <ce:section-title id="sectitle0525">7-(diethylamino)-3-(4-(6-methoxy-1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7n</ce:bold>)</ce:section-title>
                           <ce:para id="p0545" view="all">Yield 78%, yellow solid; m. p. 159–161 °C; IR (KBr) <ce:italic>ν</ce:italic> 3441, 2923, 2852, 1711, 1621, 1517, 1416, 1353, 1225, 1132, 1044, 994, 815, 551 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.02 (s, 1H), 7.80 (s, 1H), 7.60 (d, <ce:italic>J</ce:italic> = 8.3 Hz, 1H), 7.57 (d, <ce:italic>J</ce:italic> = 1.9 Hz, 1H), 7.50 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 1H), 7.26 (dd, <ce:italic>J</ce:italic> = 8.3, 2.1 Hz, 1H), 6.75 (dd, <ce:italic>J</ce:italic> = 9.0, 2.3 Hz, 1H), 6.56 (d, <ce:italic>J</ce:italic> = 2.1 Hz, 1H), 3.88 (s, 3H), 3.72–3.37 (m, 8H), 3.49 (q, <ce:italic>J</ce:italic> = 7.0 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 7.0 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.38, 162.43, 158.51, 158.27, 156.70, 151.34, 144.27, 137.82, 134.10, 132.77, 130.21, 128.32, 121.09, 119.48, 115.54, 109.45, 107.78, 107.14, 96.30, 59.77, 56.42, 44.20, 12.21; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 574.1618 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 574.1618, C<ce:inf loc="post">28</ce:inf>H<ce:inf loc="post">29</ce:inf>N<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">7</ce:inf>S).</ce:para>
                        </ce:section>
                        <ce:section id="sec4.1.6.15" view="all">
                           <ce:label>4.1.6.15</ce:label>
                           <ce:section-title id="sectitle0530">7-(diethylamino)-3-(4-(1, 1-dioxidobenzo[<ce:italic>b</ce:italic>]thiophene-2-carbonyl) piperazine-1-carbonyl)-2H-chromen-2-one (<ce:bold>7o</ce:bold>)</ce:section-title>
                           <ce:para id="p0550" view="all">Yield 78%, yellow solid; m. p. 146–147 °C; IR (KBr) <ce:italic>ν</ce:italic> 3438, 2923, 1712, 1620, 1517, 1416, 1354, 1308, 1225, 1192, 1152, 1131, 994, 819, 760, 546 cm<ce:sup loc="post">−1</ce:sup>; <ce:sup loc="pre">1</ce:sup>H NMR (600 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 8.02 (s, 1H), 7.91 (t, <ce:italic>J</ce:italic> = 13.1 Hz, 1H), 7.87 (d, <ce:italic>J</ce:italic> = 21.9 Hz, 1H), 7.75 (t, <ce:italic>J</ce:italic> = 7.1 Hz, 1H), 7.69 (d, <ce:italic>J</ce:italic> = 6.7 Hz, 2H), 7.50 (d, <ce:italic>J</ce:italic> = 8.9 Hz, 1H), 6.75 (dd, <ce:italic>J</ce:italic> = 8.8, 1.5 Hz, 1H), 6.56 (s, 1H), 3.74–3.38 (m, 8H), 3.49 (q, <ce:italic>J</ce:italic> = 6.9 Hz, 4H), 1.12 (t, <ce:italic>J</ce:italic> = 6.9 Hz, 6H); <ce:sup loc="pre">13</ce:sup>C NMR (151 MHz, DMSO‑<ce:italic>d</ce:italic>
                              <ce:inf loc="post">6</ce:inf>) <ce:italic>δ</ce:italic> 164.38, 158.51, 158.04, 156.70, 151.34, 144.29, 135.80, 135.67, 134.50, 132.15, 131.85, 130.21, 129.23, 127.10, 121.46, 115.52, 109.44, 107.14, 96.29, 59.77, 44.619, 12.21; HRMS (ESI) <ce:italic>m</ce:italic>/<ce:italic>z</ce:italic> 544.1512 [M+Na]<ce:sup loc="post">+</ce:sup> (calcd for 544.1513, C<ce:inf loc="post">27</ce:inf>H<ce:inf loc="post">27</ce:inf>N<ce:inf loc="post">3</ce:inf>NaO<ce:inf loc="post">6</ce:inf>S).</ce:para>
                        </ce:section>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.2" view="all">
                     <ce:label>4.2</ce:label>
                     <ce:section-title id="sectitle0535">Cell line and cell culture</ce:section-title>
                     <ce:para id="p0555" view="all">All cell lines were purchased from Cell Bank of Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Shanghai, China). Cancer cell line human breast carcinoma MDA-MB-231, human hepatocellular carcinoma HepG2 cells, human colonic carcinoma HCT-116 cells and human colonic epithelial L02 cells were cultured in Dulbecco modified Eagle medium (DMEM) plus 10% (v/v) fetal bovine serum (FBS), 50 μg/mL penicillin and 50 μg/mL streptomycin. Human breast carcinoma MCF-7 cells, human normal breast MCF-10 A cells and mouse breast carcinoma 4T1 cells were cultured in RPMI 1640 medium, supplemented with 10% (v/v) FBS. All cell lines were incubated at 37 °C in a humidified atmosphere containing 5% CO<ce:inf loc="post">2</ce:inf>.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.3" view="all">
                     <ce:label>4.3</ce:label>
                     <ce:section-title id="sectitle0540">Cell viability assays</ce:section-title>
                     <ce:para id="p0560" view="all">Cell viability was measured <ce:italic>via</ce:italic> MTT assay. Cells (MDA-MB-231, HepG2, HCT-116, MCF-7, MCF-10 A, L02) were seeded in 96-well culture plates at a density of 3000–6000 cells per well. After overnight incubation, the cells were treated with different concentrations of test compounds for 48 h at 37 °C. The percentage of DMSO in the medium not exceeded 0.1% MTT (5 mg/mL) was dissolved in PBS and filter-sterilized, then 20 μL of the prepared MTT solution was added to each well and the cells were incubated for another 3.5 h until a purple precipitate was visible. The formed formazan crystals were dissolved in DMSO (150 μL/well) by continuous shaking for 10 min. The absorbance was read by an ELISA reader (SpectraMax Plus 384, Molecular Devices, Sunnyvale, CA) at a test wavelength of 570 nm and a reference wavelength of 630 nm. The cytotoxic activity was expressed as the IC<ce:inf loc="post">50</ce:inf> values. All experiments were conducted in triplicate and repeated more than three times.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.4" view="all">
                     <ce:label>4.4</ce:label>
                     <ce:section-title id="sectitle0545">Colony forming assay</ce:section-title>
                     <ce:para id="p0565" view="all">The anti-proliferative activity of the compound <ce:bold>7a</ce:bold> was measured using colony forming assays. MDA-MB-231 cells were plated in 6-well culture plates (1000 cells per well), and treated by compound <ce:bold>7a</ce:bold> at different concentrations for 24 h. Then culture medium containing was discarded, and cells were subcultured to fresh medium. Cells were allowed to grow for 10–14 days until the colonies were visible. The cells in plates were then stained with crystal violet solution (Sigma Aldrich, St. Louis, MO) and the results of colonies were taken photos manually.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.5" view="all">
                     <ce:label>4.5</ce:label>
                     <ce:section-title id="sectitle0550">Cell apoptosis analysis</ce:section-title>
                     <ce:para id="p0570" view="all">Apoptosis was determined by flow cytometry in accordance with the manufacturer's instructions. An Annexin V-FITC/PI double-staining assay was used to analyze the apoptosis, for which 3.0 × 10<ce:sup loc="post">5</ce:sup> MDA-MB-231 cells were incubated with various concentrations of compound <ce:bold>7a</ce:bold> for 24 h. Then the cells were harvested, washed and stained with 5 μL Annexin V-FITC and 10 μL propidium iodide at room temperature in the dark for 15 min. Cells were then analyzed by flow cytometry (488 nm excitation and 525 nm emission filters) using BD Accuri C6 flow cytometer (Becton & Dickinson Company, Franklin Lakes, NJ).</ce:para>
                  </ce:section>
                  <ce:section id="sec4.6" view="all">
                     <ce:label>4.6</ce:label>
                     <ce:section-title id="sectitle0555">Fluorescence colocalization</ce:section-title>
                     <ce:para id="p0575" view="all">MDA-MB-231 cells and MCF-7 cells were seeded into 96-well plate and cultured in medium supplemented with 10% FBS in an atmosphere of 5% CO<ce:inf loc="post">2</ce:inf> at 37 °C. After 24 h, 100 μL of fresh media containing compound <ce:bold>7a</ce:bold> was added and incubated for 60 min. After treatment, the medium was removed, and the cells were washed with PBS for three times. Cells were then incubated with 1 μM MitoTracker Red or 1 μM LysoTracker Red for another 30 min after being fixed in 4% of paraformaldehyde for 10 min. The images of cells were taken under an Image Xpress Micro Confocal analysis.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.7" view="all">
                     <ce:label>4.7</ce:label>
                     <ce:section-title id="sectitle0560">Western blotting assays</ce:section-title>
                     <ce:para id="p0580" view="all">Protein levels were determined by standard western blotting. MDA-MB-231 cells were incubated with various concentrations of compound <ce:bold>7a</ce:bold> (1–4 μM) or <ce:bold>Stattic</ce:bold> (4 μM) for 24 h. Harvesting after trypsinisation, cells were treated with 1 × RIPA lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.25% deoxycholic acid, 1% NP-40, 1 mM EDTA and protease inhibitors PMSF) (Amresco, Solon, USA) to extract the total proteins. An aliquot of proteins from the total cell lysates (40–80 μg per lane) was separated by sodium dodecyl sulfate (10%) polyacrylamide gel electrophoresis (SDS-PAGE, BioRad Laboratories, Hercules, CA), wet-transferred to PDVF membrane (BioRad Laboratories, Hercules, CA) and blotted with primary antibodies specific for Cleaved Caspase-9, Caspase-9, Cleaved Caspase-3, Caspase-3, PARP, Cleaved PARP, STAT3, p-STAT3 (Y705), p-STAT3 (S727), STAT1, p-STAT1 (Y701), <ce:italic>p</ce:italic>-JAK2, Src, <ce:italic>p</ce:italic>-Src, <ce:italic>p</ce:italic>-Erk1/2, Bcl-2, Cyclin D1 and GAPDH, probed with secondary isotype specific antibodies tagged with horseradish peroxidase (Cell Signaling Technology). Bound immunocomplexes were detected using ChemiDOC™ XRS + system (Bio-Rad Laboratories, Hercules, CA).</ce:para>
                  </ce:section>
                  <ce:section id="sec4.8" view="all">
                     <ce:label>4.8</ce:label>
                     <ce:section-title id="sectitle0565">Electrophoretic mobility shift assay (EMSA) of DNA-binding activity</ce:section-title>
                     <ce:para id="p0585" view="all">MDA-MB-231 cells were incubated overnight and then treated with compound <ce:bold>7a</ce:bold> (1–4 μM) or <ce:bold>Stattic</ce:bold> (4 μM) in fresh medium for 24 h and the cells were harvested. Nuclear extract preparations of MDA-MB-231 cells and EMSA analysis were carried out using LightShift® Chemiluminescent EMSA Kit (Thermo Scientific, Inc.) following the manufacturer's recommended protocol. The <ce:sup loc="pre">32</ce:sup>P labeled oligonucleotide hSIE probe was used to bind STAT3.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.9" view="all">
                     <ce:label>4.9</ce:label>
                     <ce:section-title id="sectitle0570">Mitochondrial membrane potential detection</ce:section-title>
                     <ce:para id="p0590" view="all">Mitochondrial membrane potential was determined using the mitochondrial membrane potential assay kit with JC-1 (Beyotime, Nanjing, China) following the manufacturer's recommended protocol. MDA-MB-231 cells were plated in 6-well culture plates (3 × 10<ce:sup loc="post">5</ce:sup> cells per well), and treated with different concentrations of compound <ce:bold>7a</ce:bold> for 24 h. Cells were harvested at 2000 rpm for 5 min and then washed twice with ice-cold PBS, followed by resuspension in JC-1 (5 mg/mL) and incubation at 37 °C for 20 min. After the cells were rinsed three times and suspended in the JC-1 buffer, the JC-1 fluorescence was observed by flow cytometry.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.10" view="all">
                     <ce:label>4.10</ce:label>
                     <ce:section-title id="sectitle0575">ROS levels detection</ce:section-title>
                     <ce:para id="p0595" view="all">The levels of intracellular ROS were measured by using the oxidation-sensitive dye 5, 6-carboxy-2ʹ, 7ʹ-dichlorofluorescein diacetate (DCFH-DA). MDA-MB-231 cells were seeded in 6-well plates at a density of 3 × 10<ce:sup loc="post">5</ce:sup> cells/well and treated with various concentrations of compound <ce:bold>7a</ce:bold> for 24 h. After washed three times with serum-free medium and incubated with 10 μM DCFH-DA for 30 min at 37 °C in the dark, cells were washed again, harvested and resuspended in serum-free medium. The samples were then detected by flow cytometry using BD Accuri C6 flow cytometer.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.11" view="all">
                     <ce:label>4.11</ce:label>
                     <ce:section-title id="sectitle0580">Molecular docking</ce:section-title>
                     <ce:para id="p0600" view="all">Molecular docking studies were performed to dock our designed small molecules to predict their binding modes and approximate binding free energies to the STAT3 SH2 dimerization sites with computational docking program AutoDock4.2. Compounds <ce:bold>7a</ce:bold> were docked using the Lamarckian Genetic Algorithm. The Schrodinger software was used to prepare the macromolecule and ligand. Gasteiger charges were assigned to the ligands by AutoDock Tools. AutoGrid maps were further precomputed for all atom types in the ligand set. After completing 10 million energy evaluations, the root-meansquare deviation threshold was set as 1.5 Å and all the conformations of the ligands in the binding pocket of the macromolecule were clustered. The lowest energy clusters were identified and binding energies were evaluated.</ce:para>
                  </ce:section>
                  <ce:section id="sec4.12" view="all">
                     <ce:label>4.12</ce:label>
                     <ce:section-title id="sectitle0585">
                        <ce:italic>In vivo</ce:italic> tumor studies</ce:section-title>
                     <ce:para id="p0605" view="all">Adult female BALB/c mice (6 weeks of age), of Specified-Pathogens Free (SPF) grade, were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. Mice were injected in the right flank area with 4 × 10<ce:sup loc="post">6</ce:sup> breast cancer 4T1 cells in 200 μL of PBS and then randomly divided into three groups (6–8 mice per group) after tumors with a diameter of 3 mm were established. The tumor-bearing mice were intraperitoneally administered with compound <ce:bold>7a</ce:bold> (10 or 20 mg/kg) or vehicle for 14 consecutive days. The tumor size was measured by caliper every 2 days to document tumor growth and calculated by the formula: V = 0.52 × <ce:italic>a</ce:italic>
                        <ce:sup loc="post">2</ce:sup> × <ce:italic>b</ce:italic> (<ce:italic>a</ce:italic> is the smallest superficial diameter and <ce:italic>b</ce:italic> is the largest superficial diameter). Drugs were prepared in a hydroxypropyl-<ce:italic>beta</ce:italic>-cyclodextrin and DMSO mixture (30% hydroxypropyl-<ce:italic>beta</ce:italic>-cyclodextrin, 10% DMSO and 60% saline) to give a 1 mg/mL or 2 mg/mL solution. After 15 days of treatment, all mice were killed and tumors were segregated, weighed, and stored at −80 °C for later use. Tumor inhibitory ratio TI (%) was calculated as TI (%) = (1 - W<ce:inf loc="post">T</ce:inf>/W<ce:inf loc="post">V</ce:inf>) × 100, where W<ce:inf loc="post">T</ce:inf> and W<ce:inf loc="post">V</ce:inf> were the average tumor weights of the treated and vehicle group respectively.</ce:para>
                  </ce:section>
               </ce:section>
            </ce:sections>
            <ce:acknowledgment id="ack0010" view="all">
               <ce:section-title id="sectitle0590">Acknowledgments</ce:section-title>
               <ce:para id="p0610" view="all">This research work was supported by <ce:grant-sponsor id="gs1" sponsor-id="https://doi.org/10.13039/501100001809" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">National Natural Science Foundation of China</ce:grant-sponsor> (Grant No.<ce:grant-number refid="gs1">81673298</ce:grant-number> and No. <ce:grant-number refid="gs1">81402791</ce:grant-number>), <ce:grant-sponsor id="gs2" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Natural Science Foundation of the Jiangsu Higher Education Institutions of China</ce:grant-sponsor> for Excellent Young Talents (Grant No. <ce:grant-number refid="gs2">BK20180077</ce:grant-number>), <ce:grant-sponsor id="gs3" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Program for Changjiang Scholars and Innovative Research Team</ce:grant-sponsor> in University (<ce:grant-number refid="gs3">IRT_15R63</ce:grant-number>), <ce:grant-sponsor id="gs4" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">Postgraduate Research & Practice Innovation Program of Jiangsu Province</ce:grant-sponsor> (<ce:grant-number refid="gs4">KYCX17_0731</ce:grant-number>).</ce:para>
            </ce:acknowledgment>
            <ce:appendices view="all">
               <ce:section id="appsec1" view="extended">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0595">Supplementary data</ce:section-title>
                  <ce:para id="p0615" view="all">The following is/are the supplementary data to this article:<ce:display>
                        <ce:e-component id="ec1">
                           <ce:link locator="mmc1" xlink:type="simple" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/46.1" xlink:href="pii:S0223523419303307/mmc1"/></ce:link>
                        </ce:e-component>
                     </ce:display>
                  </ce:para>
               </ce:section>
               <ce:section id="appsec2" view="compact-standard">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0600">Supplementary data</ce:section-title>
                  <ce:para id="p0620" view="all">Supplementary data to this article can be found online at <ce:inter-ref xlink:href="https://doi.org/10.1016/j.ejmech.2019.04.024" id="intref0015" xlink:type="simple">https://doi.org/10.1016/j.ejmech.2019.04.024</ce:inter-ref>.</ce:para>
               </ce:section>
            </ce:appendices>
         </body>
         <tail view="all">
            <ce:bibliography id="cebib0010" view="all">
               <ce:section-title id="sectitle0605">References</ce:section-title>
               <ce:bibliography-sec id="cebibsec0010" view="all">
                  <ce:bib-reference id="bib1">
                     <ce:label>[1]</ce:label>
                     <sb:reference id="sref1">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Abroun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Saki</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Ahmadvand</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Asghari</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Salari</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Rahim</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STATs: an old story, yet mesmerizing</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell J</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>17</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>395</sb:first-page>
                              <sb:last-page>411</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib2">
                     <ce:label>[2]</ce:label>
                     <sb:reference id="sref2">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Bromberg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The role of STATs in transcriptional control and their impact on cellular function</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>2000</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2468</sb:first-page>
                              <sb:last-page>2473</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib3">
                     <ce:label>[3]</ce:label>
                     <sb:reference id="sref3">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.L.</ce:given-name>
                                 <ce:surname>Carpenter</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.W.</ce:given-name>
                                 <ce:surname>Lo</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT3 target genes relevant to human cancers</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancers</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>897</sb:first-page>
                              <sb:last-page>925</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib4">
                     <ce:label>[4]</ce:label>
                     <sb:reference id="sref4">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STATs and gene regulation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>277</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1630</sb:first-page>
                              <sb:last-page>1635</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib5">
                     <ce:label>[5]</ce:label>
                     <sb:reference id="sref5">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Laudisi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Cherubini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Monteleone</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Stolfi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT3 interactors as potential therapeutic targets for cancer treatment</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Mol. Sci.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1787</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib6">
                     <ce:label>[6]</ce:label>
                     <sb:reference id="sref6">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Bowman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Garcia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STATs in oncogenesis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>2000</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2474</sb:first-page>
                              <sb:last-page>2488</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib7">
                     <ce:label>[7]</ce:label>
                     <sb:reference id="sref7">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Crowe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Goldstein</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Oncol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>41</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1181</sb:first-page>
                              <sb:last-page>1191</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib8">
                     <ce:label>[8]</ce:label>
                     <sb:reference id="sref8">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.D.</ce:given-name>
                                 <ce:surname>Beebe</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.Y.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.T.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Pharmacol. Ther.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>191</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>74</sb:first-page>
                              <sb:last-page>91</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib9">
                     <ce:label>[9]</ce:label>
                     <sb:reference id="sref9">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Bernardi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Scorrano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Colonna</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Petronilli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Di Lisa</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondria and cell death. Mechanistic aspects and methodological issues</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Biochem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>264</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>687</sb:first-page>
                              <sb:last-page>701</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib10">
                     <ce:label>[10]</ce:label>
                     <sb:reference id="sref10">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.R.</ce:given-name>
                                 <ce:surname>Duchen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondria in health and disease: perspectives on a new mitochondrial biology</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Aspect. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>25</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>365</sb:first-page>
                              <sb:last-page>451</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib11">
                     <ce:label>[11]</ce:label>
                     <sb:reference id="sref11">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Gogvadze</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Orrenius</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Zhivotovsky</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondria in cancer cells: what is so special about them?</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Trends Cell Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>165</sb:first-page>
                              <sb:last-page>173</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib12">
                     <ce:label>[12]</ce:label>
                     <sb:reference id="sref12">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.M.</ce:given-name>
                                 <ce:surname>McBride</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Neuspiel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wasiak</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondria: more than just a powerhouse</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Curr. Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>16</sb:volume-nr>
                              </sb:series>
                              <sb:date>2006</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>R551</sb:first-page>
                              <sb:last-page>R560</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib13">
                     <ce:label>[13]</ce:label>
                     <sb:reference id="sref13">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Modica-Napolitano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.K.</ce:given-name>
                                 <ce:surname>Singh</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondrial dysfunction in cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mitochondrion</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>4</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>755</sb:first-page>
                              <sb:last-page>762</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib14">
                     <ce:label>[14]</ce:label>
                     <sb:reference id="sref14">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.W.</ce:given-name>
                                 <ce:surname>Tait</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.R.</ce:given-name>
                                 <ce:surname>Green</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondria and cell signalling</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Cell Sci.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>125</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>807</sb:first-page>
                              <sb:last-page>815</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib15">
                     <ce:label>[15]</ce:label>
                     <sb:reference id="sref15">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Gorrini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.S.</ce:given-name>
                                 <ce:surname>Harris</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.W.</ce:given-name>
                                 <ce:surname>Mak</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Modulation of oxidative stress as an anticancer strategy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Drug Discov.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>12</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>931</sb:first-page>
                              <sb:last-page>947</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib16">
                     <ce:label>[16]</ce:label>
                     <sb:reference id="sref16">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Ye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yuan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Lou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Fan</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondria-targeted lupane triterpenoid derivatives and their selective apoptosis-inducing anticancer mechanisms</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>60</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>6353</sb:first-page>
                              <sb:last-page>6363</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib17">
                     <ce:label>[17]</ce:label>
                     <sb:reference id="sref17">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.B.</ce:given-name>
                                 <ce:surname>Aggarwal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.B.</ce:given-name>
                                 <ce:surname>Kunnumakkara</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.B.</ce:given-name>
                                 <ce:surname>Harikumar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.R.</ce:given-name>
                                 <ce:surname>Gupta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.T.</ce:given-name>
                                 <ce:surname>Tharakan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Koca</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Dey</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Sung</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Ann. N. Y. Acad. Sci.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>1171</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>59</sb:first-page>
                              <sb:last-page>76</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib18">
                     <ce:label>[18]</ce:label>
                     <sb:reference id="sref18">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Aznar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.F.</ce:given-name>
                                 <ce:surname>Valeron</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.V.</ce:given-name>
                                 <ce:surname>del Rincon</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.F.</ce:given-name>
                                 <ce:surname>Perez</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Perona</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>Lacal</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Biol. Cell</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>12</sb:volume-nr>
                              </sb:series>
                              <sb:date>2001</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3282</sb:first-page>
                              <sb:last-page>3294</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib19">
                     <ce:label>[19]</ce:label>
                     <sb:reference id="sref19">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.G.</ce:given-name>
                                 <ce:surname>Mackenzie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Alston</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ouyang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Vrankova</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Mattheolabakis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.P.</ce:given-name>
                                 <ce:surname>Constantinides</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Rigas</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>PLoS One</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>8</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:article-number>e61532</sb:article-number>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib20">
                     <ce:label>[20]</ce:label>
                     <sb:reference id="sref20">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.A.</ce:given-name>
                                 <ce:surname>Meier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Larner</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Toward a new STATe: the role of STATs in mitochondrial function</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Semin. Immunol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>26</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>20</sb:first-page>
                              <sb:last-page>28</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib21">
                     <ce:label>[21]</ce:label>
                     <sb:reference id="sref21">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Rincon</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondrial STAT3, the need for design thinking</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Biol. Sci.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>12</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>532</sb:first-page>
                              <sb:last-page>544</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib22">
                     <ce:label>[22]</ce:label>
                     <sb:reference id="sref22">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Sheng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Teng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Zinc improves mitochondrial respiratory function and prevents mitochondrial ROS generation at reperfusion by phosphorylating STAT3 at Ser(727)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Mol. Cell. Cardiol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>118</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>169</sb:first-page>
                              <sb:last-page>182</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib23">
                     <ce:label>[23]</ce:label>
                     <sb:reference id="sref23">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Raje</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.A.</ce:given-name>
                                 <ce:surname>Yakovlev</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Yacoub</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Szczepanek</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Meier</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Derecka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Hu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Sisler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Hamed</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.J.</ce:given-name>
                                 <ce:surname>Lesnefsky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Valerie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Dent</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Larner</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondrial localized STAT3 promotes breast cancer growth <ce:italic>via</ce:italic> phosphorylation of serine 727</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>288</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>31280</sb:first-page>
                              <sb:last-page>31288</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib24">
                     <ce:label>[24]</ce:label>
                     <sb:reference id="sref24">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Mo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Lu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Lan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Lu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Paclitaxel induces apoptosis of esophageal squamous cell carcinoma cells by downregulating STAT3 phosphorylation at Ser727</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncol. Rep.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>37</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2237</sb:first-page>
                              <sb:last-page>2244</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib25">
                     <ce:label>[25]</ce:label>
                     <sb:reference id="sref25">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Wegrzyn</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Potla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.J.</ce:given-name>
                                 <ce:surname>Chwae</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.B.</ce:given-name>
                                 <ce:surname>Sepuri</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Koeck</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Derecka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Szczepanek</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Szelag</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Gornicka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Moh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Moghaddas</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Bobbili</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Cichy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Dulak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.P.</ce:given-name>
                                 <ce:surname>Baker</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Wolfman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Stuehr</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.O.</ce:given-name>
                                 <ce:surname>Hassan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.Y.</ce:given-name>
                                 <ce:surname>Fu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Avadhani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.I.</ce:given-name>
                                 <ce:surname>Drake</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Fawcett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.J.</ce:given-name>
                                 <ce:surname>Lesnefsky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Larner</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Function of mitochondrial STAT3 in cellular respiration</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>323</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>793</sb:first-page>
                              <sb:last-page>797</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib26">
                     <ce:label>[26]</ce:label>
                     <sb:reference id="sref26">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.J.</ce:given-name>
                                 <ce:surname>Gough</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Corlett</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Schlessinger</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Wegrzyn</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Larner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.E.</ce:given-name>
                                 <ce:surname>Levy</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondrial STAT3 supports Ras-dependent oncogenic transformation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>324</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1713</sb:first-page>
                              <sb:last-page>1716</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib27">
                     <ce:label>[27]</ce:label>
                     <sb:reference id="sref27">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Wen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zhong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.J.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>82</sb:volume-nr>
                              </sb:series>
                              <sb:date>1995</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>241</sb:first-page>
                              <sb:last-page>250</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib28">
                     <ce:label>[28]</ce:label>
                     <sb:reference id="sref28">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.M.</ce:given-name>
                                 <ce:surname>Alonso</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Asumendi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Villar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.J.</ce:given-name>
                                 <ce:surname>Gil</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Martínezmerino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.J.</ce:given-name>
                                 <ce:surname>Encío</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Migliaccio</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>New benzo(<ce:italic>b</ce:italic>)thiophenesulphonamide 1, 1-dioxide derivatives induce a reactive oxygen species-mediated process of apoptosis in tumour cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>22</sb:volume-nr>
                              </sb:series>
                              <sb:date>2003</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3759</sb:first-page>
                              <sb:last-page>3769</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib29">
                     <ce:label>[29]</ce:label>
                     <sb:reference id="sref29">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Chu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Terry</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Shen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>62</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>498</sb:first-page>
                              <sb:last-page>507</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib30">
                     <ce:label>[30]</ce:label>
                     <sb:reference id="sref30">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Xiong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Wild</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Cai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.M.</ce:given-name>
                                 <ce:surname>Flores</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Shen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>82</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>195</sb:first-page>
                              <sb:last-page>203</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib31">
                     <ce:label>[31]</ce:label>
                     <sb:reference id="sref31">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Ji</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Ma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Fan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Mao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Qiao</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Novel 2-carbonylbenzo[<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide derivatives as potent inhibitors of STAT3 signaling pathway</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1010</sb:first-page>
                              <sb:last-page>1014</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib32">
                     <ce:label>[32]</ce:label>
                     <sb:reference id="sref32">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Schust</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Sperl</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Hollis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.U.</ce:given-name>
                                 <ce:surname>Mayer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Berg</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Stattic: a small-molecule inhibitor of STAT3 activation and dimerization</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Chem. Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:date>2006</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1235</sb:first-page>
                              <sb:last-page>1242</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib33">
                     <ce:label>[33]</ce:label>
                     <sb:reference id="sref33">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Ma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Chao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Kong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Sci. Rep.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>7</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>46352</sb:first-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib34">
                     <ce:label>[34]</ce:label>
                     <sb:reference id="sref34">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Ma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Kong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Antagonizing STAT3 activation with benzo[<ce:italic>b</ce:italic>]thiophene 1, 1-dioxide based small molecules</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>125</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>538</sb:first-page>
                              <sb:last-page>550</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib35">
                     <ce:label>[35]</ce:label>
                     <sb:reference id="sref35">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.V.</ce:given-name>
                                 <ce:surname>Jokerst</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.S.</ce:given-name>
                                 <ce:surname>Gambhir</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Molecular imaging with theranostic nanoparticles</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Acc. Chem. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>44</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1050</sb:first-page>
                              <sb:last-page>1060</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib36">
                     <ce:label>[36]</ce:label>
                     <sb:reference id="sref36">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.S.</ce:given-name>
                                 <ce:surname>Aw</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Kurian</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Losic</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Polymeric micelles for multidrug delivery and combination therapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Chem. Eur J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>12586</sb:first-page>
                              <sb:last-page>12601</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib37">
                     <ce:label>[37]</ce:label>
                     <sb:reference id="sref37">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Bardhan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Lal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Joshi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.J.</ce:given-name>
                                 <ce:surname>Halas</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Theranostic nanoshells: from probe design to imaging and treatment of cancer</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Acc. Chem. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>44</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>936</sb:first-page>
                              <sb:last-page>946</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib38">
                     <ce:label>[38]</ce:label>
                     <sb:reference id="sref38">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Hori</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Norinobu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Sato</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Arita</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Shirakawa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Kikuchi</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Development of fluorogenic probes for quick no-wash live-cell imaging of intracellular proteins</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Am. Chem. Soc.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>135</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>12360</sb:first-page>
                              <sb:last-page>12365</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib39">
                     <ce:label>[39]</ce:label>
                     <sb:reference id="sref39">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Rong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.H.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Cheng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.S.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.Y.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.Y.</ce:given-name>
                                 <ce:surname>Qin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.Z.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A coumarin derivative as a fluorogenic glycoproteomic probe for biological imaging</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Chem. Commun.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>50</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>667</sb:first-page>
                              <sb:last-page>669</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib40">
                     <ce:label>[40]</ce:label>
                     <sb:reference id="sref40">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Jiang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Cell-permeable iminocoumarine-based fluorescent dyes for mitochondria</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Org. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2884</sb:first-page>
                              <sb:last-page>2887</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib41">
                     <ce:label>[41]</ce:label>
                     <sb:reference id="sref41">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Luo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Cai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Miao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.H.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Xie</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.S.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Probing the anticancer action of oridonin with fluorescent analogues: visualizing subcellular localization to mitochondria</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>59</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5022</sb:first-page>
                              <sb:last-page>5034</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib42">
                     <ce:label>[42]</ce:label>
                     <sb:reference id="sref42">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Ba</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Gu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Fluorescent coumarin-artemisinin conjugates as mitochondria-targeting theranostic probes for enhanced anticancer activities</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Chemistry</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>21</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>17415</sb:first-page>
                              <sb:last-page>17421</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib43">
                     <ce:label>[43]</ce:label>
                     <sb:reference id="sref43">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Wei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Ye</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Synthesis, biological evaluation of fluorescent 23-hydroxybetulinic acid probes, and their cellular localization studies</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>9</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1030</sb:first-page>
                              <sb:last-page>1034</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib44">
                     <ce:label>[44]</ce:label>
                     <sb:reference id="sref44">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.F.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.T.</ce:given-name>
                                 <ce:surname>Tai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.Y.</ce:given-name>
                                 <ce:surname>Hsu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.W.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.Y.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.J.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.W.</ce:given-name>
                                 <ce:surname>Shiau</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>55</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>220</sb:first-page>
                              <sb:last-page>227</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib45">
                     <ce:label>[45]</ce:label>
                     <sb:reference id="sref45">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Yuan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.W.</ce:given-name>
                                 <ce:surname>Jin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.R.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.T.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.M.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Cui</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>157</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>887</sb:first-page>
                              <sb:last-page>897</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib46">
                     <ce:label>[46]</ce:label>
                     <sb:reference id="sref46">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>An</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Sang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Ju</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Tong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Luo</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>162</sb:volume-nr>
                              </sb:series>
                              <sb:date>2019</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>543</sb:first-page>
                              <sb:last-page>554</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib47">
                     <ce:label>[47]</ce:label>
                     <sb:reference id="sref47">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Saturnino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Palladino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Napoli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.S.</ce:given-name>
                                 <ce:surname>Sinicropi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Botta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Sala</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Carcereri de Prati</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Novellino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Suzuki</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Synthesis and biological evaluation of new N-alkylcarbazole derivatives as STAT3 inhibitors: preliminary study</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>60</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>112</sb:first-page>
                              <sb:last-page>119</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib48">
                     <ce:label>[48]</ce:label>
                     <sb:reference id="sref48">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>62</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>301</sb:first-page>
                              <sb:last-page>310</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib49">
                     <ce:label>[49]</ce:label>
                     <sb:reference id="sref49">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Peng</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Du</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Shi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Du</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Design, synthesis and activity of BBI608 derivatives targeting on stem cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>151</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>39</sb:first-page>
                              <sb:last-page>50</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib50">
                     <ce:label>[50]</ce:label>
                     <sb:reference id="sref50">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Ma</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Kong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>124</sb:volume-nr>
                              </sb:series>
                              <sb:date>2016</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1006</sb:first-page>
                              <sb:last-page>1018</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib51">
                     <ce:label>[51]</ce:label>
                     <sb:reference id="sref51">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Guo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Cai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Song</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Kong</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>151</sb:volume-nr>
                              </sb:series>
                              <sb:date>2018</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>752</sb:first-page>
                              <sb:last-page>764</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib52">
                     <ce:label>[52]</ce:label>
                     <sb:reference id="sref52">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Kroemer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Galluzzi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Brenner</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Mitochondrial membrane permeabilization in cell death</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Physiol. Rev.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>87</sb:volume-nr>
                              </sb:series>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>99</sb:first-page>
                              <sb:last-page>163</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib53">
                     <ce:label>[53]</ce:label>
                     <sb:reference id="sref53">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Demaria</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Camporeale</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Poli</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT3 and metabolism: how many ways to use a single molecule?</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Int. J. Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>135</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1997</sb:first-page>
                              <sb:last-page>2003</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib54">
                     <ce:label>[54]</ce:label>
                     <sb:reference id="sref54">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Chung</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Uchida</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.C.</ce:given-name>
                                 <ce:surname>Grammer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Blenis</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Mol. Cell Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>17</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>6508</sb:first-page>
                              <sb:last-page>6516</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib55">
                     <ce:label>[55]</ce:label>
                     <sb:reference id="sref55">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Nayak</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Kumar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Chakraborty</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.U.</ce:given-name>
                                 <ce:surname>Rasool</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Amin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Katoch</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Gopinath</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Mahajan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.K.</ce:given-name>
                                 <ce:surname>Zilla</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Rah</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.G.</ce:given-name>
                                 <ce:surname>Gandhi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Ali</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.D.</ce:given-name>
                                 <ce:surname>Kumar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Goswami</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell Death Differ.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>24</sb:volume-nr>
                              </sb:series>
                              <sb:date>2017</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1275</sb:first-page>
                              <sb:last-page>1287</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib56">
                     <ce:label>[56]</ce:label>
                     <sb:reference id="sref56">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zeng</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A novel FRET-based ratiometric fluorescent probe for highly sensitive detection of hydrogen sulfide</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>RSC Adv.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>5</sb:volume-nr>
                              </sb:series>
                              <sb:date>2015</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>17797</sb:first-page>
                              <sb:last-page>17801</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item></xocs:doc></originaltext></full-text-retrieval-response>